ChAdOx1 nCoV-19

AXP000167.1 · Vaccine

Platform
chimpanzee adenovirus (ChAdOx1, non-replicating)
Targets
SARS-CoV-2 S
Originator
University of Oxford (Jenner Institute)
Sponsor
AstraZeneca

Names

NameTypeSource
ChAdOx1 nCoV-19preferred name, codecurator, wikidata
Covishieldbrandwikidata
Vaxzevriabrandwikidata
AZD1222codewikidata

Virus

Role
Vaccine vector
Family
Adenoviridae
Virus
chimpanzee adenovirus Y25
Strain
ChAdOx1
Replication
non replicating
Modifications
replication-deficient chimpanzee adenovirus vector; essential replication genes removed and replaced by the spike cassette
Transgenes
SARS-CoV-2 spike
Route
intramuscular
Source
evidence

Approvals

AgencyRegionDateStatusBrandIndicationSource
MHRAUK2020-12-30conditionalVaxzevria (COVID-19 Vaccine AstraZeneca)Active immunisation to prevent COVID-19 (temporary authorisation for emergency supply)source
EMAEU2021-01-29conditionalVaxzevriaActive immunisation to prevent COVID-19source

Clinical trials (59)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT05387317Evaluation of COVID-19 Vaccines Given as a Booster in Healthy Adults in Indonesia (MIACoV Indonesia)WithdrawnPhase 32024-042025-010COVID-19
NCT05534035Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and OlderUnknownPhase 32023-02-032023-04-30450SARS-CoV-2 Infection
NCT05542693Safety and Immunogenicity of the RNA MCTI CIMATEC HDT VaccineUnknownPhase 22023-012023-03300COVID-19; COVID-19 Vaccine
NCT07134725Safety and Immunogenicity of a Chimeric Recombinant Covid19 Vaccine SpiN-Tec MCTI UFMGCompletedPhase 1/22022-11-232023-05-22432COVID - 19
NCT05572879A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy AdultsCompletedPhase 32022-10-012023-06-232600COVID-19
NCT05198596A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 in Adults Aged 18 Years and AboveCompletedPhase 32022-07-302022-11-04250COVID-19 Vaccine
NCT05697705Effectiveness of the Oxford-AstraZeneca COVID-19 Vaccine as a 2nd Booster, the REFORCO-Brazil StudyCompleted2022-07-222023-05-18188814085COVID-19
NCT05603052A Phase III of COVID-19 Vaccine EuCorVac-19 in Healthy Adults Aged 18 Years and OlderCompletedPhase 32022-07-112024-01-152852COVID-19
NCT05426343A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Vaccine Compared With AZD1222CompletedPhase 32022-07-092022-10-10200COVID-19 Vaccine
NCT05343871Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing TrialCompletedPhase 42022-07-052023-07-282354COVID-19
NCT05188677Immunogenicity and Safety Study of SCB-2019 Vaccine as a Booster to COVID-19 Vaccine in AdultsCompletedPhase 32022-06-132023-06-061831COVID-19
NCT05135455VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Long-term Safety of VAXZEVRIACompleted2022-04-212023-08-31467Prevention of Infectious Disease Caused by SARS-CoV-2
NCT05283902Effectiveness, Immunogenicity and Safety of the Second Booster Dose of the Vaccine Against COVID-19 in the ElderlyCompleted2022-03-192022-06-01260COVID-19; Vaccine Adverse Reaction; Vaccine-Preventable Diseases
NCT05567471Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster DoseCompletedPhase 32022-02-262022-05-03875COVID-19 Respiratory Infection
NCT05126992EU Secondary Data Post-Authorisation Safety Study of AZD1222Completed2022-02-182024-01-245321930COVID-19, Vaccine Adverse Events of Special Interest
NCT05057897A Study of AZD1222, a Vaccine for the Prevention of COVID-19 in Immunocompromised AdultsTerminatedPhase 42022-01-312023-04-1934COVID-19, SARS-CoV-2
NCT05197153A Study to Evaluate the Safety and Immunogenicity of Booster With AZD1222, mRNA-1273, or MVC-COV1901 Against COVID-19CompletedPhase 22022-01-222022-06-01804COVID-19 Vaccine
NCT05178264Transverse Myelitis Related to SARS-CoV-2 VaccinesCompleted2021-12-102021-12-10580Vaccine Adverse Reaction
NCT05084755VAXZEVRIA Japan Post-Marketing Surveillance (PMS) for the Subjects With Underlying Disease at High-risk for Worsening COVID-19Terminated2021-11-112022-09-164Prevention of Infectious Disease Caused by SARS-CoV-2
NCT05052307A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine in BrazilCompleted2021-11-032022-06-204574Covid19
NCT05007275A Study to Determine Safety and Immunogenicity of the Candidate COVID-19 Vaccine AZD1222 Delivered by Aerosol in Healthy Adult VolunteersUnknownPhase 12021-10-102024-0628Covid19; SARS-CoV-2 Infection
NCT05011526A Study to Evaluate Immunogenicity and Safety of MVC-COV1901 Compared With AZD1222 Against COVID-19 in AdultsCompletedPhase 32021-10-082021-12-281030Covid19 Vaccine
NCT05097053A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19UnknownPhase 42021-10-072022-03200COVID-19 Vaccine
NCT05715944Incidence of COVID-19 Following Vaccination in Botswana Against SARS CoV 2CompletedPhase 32021-09-152022-12-3010888COVID-19
NCT04684446Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime-Boost Regimen for the Prevention of COVID-19CompletedPhase 1/22021-09-152021-11-26100COVID-19
NCT04914832Effectiveness of Covid-19 Vaccination in Eswatini Against SARS-CoV-2 Associated Hospitalization and DeathCompletedPhase 42021-08-302022-09-3075012COVID-19; Pneumonia, Viral
NCT04988048Collaborative Study to Evaluate Heterologous Vaccination Against Covid-19 in ArgentinaUnknownPhase 22021-08-032021-09-301760COVID-19 VACCINE; Covid19
NCT05027672Strategies for Combining the First Component of Sputnik V With Other Adenoviral or mRNA-based Vaccines.UnknownPhase 22021-07-302021-08-30348COVID-19 Vaccines
NCT04983537Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine Schemes in an Elderly PopulationUnknownPhase 22021-07-262021-09-26120COVID-19 Vaccines
NCT04760730Safety and Immunogenicity Study in Adults of AZD1222 and rAd26-S Administered as Heterologous Prime Boost Regimen for the Prevention of Coronavirus Disease 2019 (COVID-19)CompletedPhase 1/22021-07-132022-03-29100COVID-19
NCT05074368Efficacy and Safety of Heterologous and Homologous COVID-19 VaccinationCompleted2021-07-062022-04-27499Healthy Adult Volunteers
NCT04962906Study to Evaluate the Immunogenicity and Safety of Heterologous SARS-CoV-2 Vaccine SchemesCompletedPhase 22021-07-052021-08-05192COVID-19 Vaccines
NCT04730895Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.UnknownPhase 1/22021-072021-09360Covid19 Vaccine
NCT04973449Phase II/III Study of AZD2816, for the Prevention of COVID-19 in AdultsCompletedPhase 2/32021-06-272022-02-042843COVID-19; SARS-CoV-2
NCT04894435Mix and Match of the COVID-19 Vaccine for Safety and ImmunogenicityCompletedPhase 22021-06-112022-07-25669COVID-19
NCT05060861Safety, Efficacy of Chadox1 Ncov-19 Vaccine: Rapid Systematic Review and Meta AnalysisUnknown2021-06-012021-08-302000ChAdOx1 nCoV-19 Vaccine
NCT05059106EFFECTIVENESS, SAFETY AND IMMUNOGENICITY OF THE HALF DOSE OF THE VACCINE ChadOx1 nCoV-19 (AZD1222) for COVID-19UnknownPhase 2/32021-06-012022-06-0129637SARS-CoV-2
NCT04775069Antibody Response to COVID-19 Vaccines in Liver Disease PatientsCompletedPhase 42021-05-212023-09-30232Chronic Liver Disease
NCT04907331Heterologous SARS-CoV-2 Vaccination With ChAdOx-1 and BNT162b2UnknownPhase 22021-05-102021-11-303000SARS-CoV2 Infection
NCT05208983SafeTy and Efficacy of Preventative CoVID VaccinesUnknown2021-05-062024-031286COVID-19 Virus Infection; Vaccine Response
NCT04864561COV-COMPARE Immunogenicity of Vaccine VLA2001 Compared to AZD1222CompletedPhase 32021-04-262021-07-194034SARS-CoV-2 Virus Infection
NCT05378191Vaccination With COMIRNATY in Subjects With a VAXZEVRIA First DoseUnknownPhase 22021-04-222022-08-22600Covid19
NCT04834869COVID-19 Vaccines Safety Tracking (CoVaST)Recruiting2021-04-012025-12-3130000Adverse Reaction to Vaccine; COVID19 Vaccine
NCT04816019A Study of Intranasal ChAdOx1 nCOV-19CompletedPhase 12021-04-012022-09-3042Coronavirus
NCT04794946Safety and Efficacy of a Non-replicating ChAdOx1 Vector Vaccine AZD1222 (COVISHIELD), for Prevention of COVID-19 in Patients With Liver CirrhosisUnknown2021-03-192022-03-192200Liver Cirrhosis
NCT04686773Open-label, Non-randomized, Non-comparative, Phase II Study of Safety and Immunogenicity of Combination of AZD1222 and rAd26-S for COVID-19 PreventionCompletedPhase 22021-03-052021-10-30100COVID-19
NCT04885764Profiling Antibody Status and Vaccine Effectiveness in Post Vaccination With SARS CoV2 in Ain Shams UniversityUnknownPhase 2/32021-02-232021-10-014000Covid19
NCT05145348Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.Unknown2021-02-032022-06-30640Down Syndrome; SARS-CoV-2 Vaccination
NCT05133609COVID-19 VACCINE SAFETY AND EFFECTIVENESSUnknownPhase 1/22021-01-152022-08-01550SARS-CoV-2 Infection
NCT04826770Adaptive Immune Response to COVID-19 VaccinationUnknown2021-01-062021-12-1370SARS-CoV-2 Vaccination
NCT04832932The COVID-19 Back-to-Normal Study: Analysis of Multiple OutcomesUnknown2021-01-052023-01-052000COVID-19 Vaccines
NCT04540393AZD1222 Vaccine for the Prevention of COVID-19WithdrawnPhase 32020-09-022020-12-040COVID-19
NCT04516746Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in AdultsCompletedPhase 32020-08-282021-03-0532450COVID-19; SARS-CoV-2
NCT04568031Study of AZD1222 for the Prevention of COVID-19 in JapanCompletedPhase 1/22020-08-232021-11-22256COVID-19
NCT04444674COVID-19 Vaccine (ChAdOx1 nCoV-19) Trial in South African Adults With and Without HIV-infectionUnknownPhase 1/22020-06-242020-122130Coronavirus
NCT04536051A Study of a Candidate COVID-19 Vaccine (COV003)UnknownPhase 32020-06-022021-0910300Coronavirus
NCT04400838Investigating a Vaccine Against COVID-19CompletedPhase 2/32020-05-282025-02-0510811Coronavirus
NCT04324606A Study of a Candidate COVID-19 Vaccine (COV001)CompletedPhase 1/22020-04-232025-02-051077Coronavirus
NCT05110911Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and ProtectionActive not recruiting2020-04-022025-06-301500Influenza, Human; SARS-CoV-2 Infection
Unconfirmed matches (5)

Trials that mention one of the names in a weaker way (a code only in the title, a short or ambiguous name). Not counted above.

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditionsMatched by
NCT05442684A Study to Evaluate the Safety and Immunogenicity of Ad5-vector Based Vaccine Against Coronavirus Variants in Adults (≥18 Years) Immunized With 2 Doses of mRNA Vaccines Plus One Dose of Booster AZD1222 VaccineWithdrawnPhase 32022-11-302023-03-300COVID-19name in title: AZD1222
NCT05049226Third Dose Vaccination With AstraZeneca or Pfizer COVID-19 Vaccine Among Adults Received Sinovac COVID-19 VaccineCompletedPhase 22021-09-242022-02-221250COVID-19 Infection; COVID-19 VACCINEname in intervention: AZD1222
NCT05054621Immunogenicity of COVID-19 Vaccine on Heterologous ScheduleCompletedPhase 22021-09-152022-08-31100Covid-19; Healthy; Immunogenicity; Reactogenicity; Vaccinename in intervention: AZD1222
NCT04877743Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222Terminated2021-05-312021-11-2427Coronavirus Disease 2019 (COVID-19)name in title: AZD1222
NCT05076227Effect of Different SARS-CoV-2 Vaccine Schedules and Vaccination Intervals on Reactogenicity and Humoral ImmunogenicityCompleted2021-01-302022-03-271206Antibody Hypersensitivity; Immunisation Reaction; SARS-CoV2 Infection; Tolerancename in intervention: AZD1222

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 40908164Cellular and humoral immunity following two AZD1222 and two booster vaccinations in hemodialysis patients.Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi2026name in title: AZD1222
PMID 41140080A Case of Prolonged SARS-CoV-2 Shedding and HIV Co-infection: Clinical and Diagnostic Challenges.Infectious disorders drug targets2026name in abstract: Covishield
PMID 41447779Antibody concentration and function following SARS-CoV-2 vaccination decrease with age in adults and children with Down syndrome.Vaccine2026cited by trial NCT05145348
PMID 41766243Adverse drug reaction due to concomitant vaccine administration of Covishield and Hepatitis-B in a patient with multidrug allergies.Indian journal of pharmacology2026name in title: Covishield
PMID 42223472T-cell responses to primary SARS-CoV-2 vaccination in Down syndrome - From childhood to adulthood.Human vaccines & immunotherapeutics2026cited by trial NCT05145348
PMID 42480193Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: A non-inferiority, randomized, double-blind, phase IV clinical trial in Pakistan.Vaccine2026name in abstract: AZD1222
PMID 42506277Rhino-Orbital Mucormycosis Following COVID-19 Viral Vector Vaccination in an Immunocompetent Patient.Journal of fungi (Basel, Switzerland)2026name in abstract: AZD1222
PMID 42520645The Platform trial In COVID-19 priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity and safety of seven licensed COVID-19 vaccines delivered as fifth dose or subsequent boosters in immunocompetent adults.Vaccine2026name in abstract: AZD1222
PMID 42647298Subacute-Onset Anemia Following COVID-19 Vaccine Combination with ChAdOx (AstraZeneca) and BNT162b2 (BioNTech, Pfizer)-A Case Report.Reports (MDPI)2026name in abstract: ChAdOx1 nCoV-19
PMID 42694770Safe prolonged prophylactic use and tolerability of Ashwagandha following COVISHIELD™ vaccination over 24 weeks: a multicentre randomized double-blind placebo-controlled trial.Frontiers in medicine2026name in title: Covishield
PMID 42732121Atypical Intracerebral Hemorrhage With a Fatal Outcome Following the ChAdOx1 nCoV-19 Vaccine.Cureus2026name in title: ChAdOx1 nCoV-19
PMID 42800087One-year antibody kinetics and effectiveness of a BNT162b2 booster after four primary COVID-19 vaccination regimens in Mongolia.Vaccine2026name in abstract: ChAdOx1 nCoV-19
PMID 42869875Safety and immunogenicity of Thailand Government Pharmaceutical Organization (GPO) produced, COVID-19 vaccine, 10 μg HXP-GPOVac: A Phase III, double-blind, randomized trial in comparison with VAXZEVRIA.Vaccine2026name in title: Vaxzevria
PMID 42983706Coronavirus disease 2019 vaccination and reduced severity-related outcomes in high-risk groups in Thailand during the Omicron period.BMC public health2026name in abstract: AZD1222
PMID 35278060Thrombosis with thrombocytopenia after the second ChAdOx1 nCoV-19 vaccination: A possible immunological mechanism independent of anti-platelet factor 4 antibody.Asian Pacific journal of allergy and immunology2025name in title: ChAdOx1 nCoV-19
PMID 39615342Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: A randomised, comparator-controlled, phase 2 trial.Vaccine2025name in abstract: Vaxzevria
PMID 39620969Surgical Treatment of Synkinetic Eyelid Closure in Marin-amat Syndrome Complicated by Facial Palsy After COVID-19 Vaccination.The Journal of craniofacial surgery2025name in abstract: ChAdOx1 nCoV-19
PMID 39675209Predictors of severity of SARS-CoV-2 infections in Brazil: Post hoc analyses of a randomised controlled trial.Vaccine2025cited by trial NCT04536051
PMID 39711320Neutralizing antibodies against SARS-CoV-2 of vaccinated healthcare workers in Taiwan.Annals of medicine2025name in abstract: AZD1222
PMID 39765039Humoral Immune Response to SARS-CoV-2 Vaccines in Patients with Autoimmune Rheumatic Diseases.Archives of medical research2025name in abstract: AZD1222
PMID 39817585Longitudinal Follow-Up of the Specific Antibody Response to SARS-CoV-2 Vaccination in Colombia.Journal of medical virology2025name in abstract: AZD1222
PMID 40068393Second booster doses of adenoviral- and mRNA-based COVID-19 vaccines increase protection against COVID-19 hospitalization: Final analysis from the REFORCO-Brazil real-world effectiveness study during Omicron.Vaccine2025cited by trial NCT05697705
PMID 40196126Memory B cell proliferation drives differences in neutralising responses between ChAdOx1 and BNT162b2 SARS-CoV-2 vaccines.Frontiers in immunology2025cited by trial NCT05110911
PMID 40425703Serious adverse drug reactions associated with anti-SARS-CoV-2 vaccines and their reporting trends in the EudraVigilance database.Scientific reports2025name in abstract: Vaxzevria
PMID 40482902Challenges of Vaccine-Induced Thrombotic Thrombocytopenia-Related Kidney Transplantation: Venous Graft Thrombosis in a Pediatric Recipient.American journal of kidney diseases : the official journal of the National Kidney Foundation2025name in abstract: Vaxzevria
PMID 40548899Adverse Effects Related to SARS-CoV-2 Vaccination in Patients With Rheumatic Diseases and Psoriasis From Argentina.Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases2025name in abstract: ChAdOx1 nCoV-19
PMID 40595319Comparative analysis of humoral immunity kinetics following three COVID-19 vaccines in a multi-ethnic cohort of medical students and healthcare professionals across Malaysia.Scientific reports2025name in abstract: Vaxzevria
PMID 40620571Antispike IgG antibody decay after immunisation with fractional versus full booster doses of COVID-19 vaccines: a 6-month longitudinal analysis of the FRACT-COV trial in Brazil.BMJ public health2025cited by trial NCT05343871
PMID 40686533Immunogenicity and Safety of ChAdOx1 nCoV-19 (AZD1222) as a Homologous Fourth-Dose Booster: A Substudy of the Phase 3 COV003 Trial in Brazil.Mayo Clinic proceedings. Innovations, quality & outcomes2025cited by trial NCT04536051
PMID 40857840Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: Final results of a phase 2, single-blind, randomised controlled trial (COV006).Vaccine2025name in title: ChAdOx1 nCoV-19
PMID 40872863Year-Long Antibody Response to the EuCorVac-19 SARS-CoV-2 Vaccine in Healthy Filipinos.Vaccines2025cited by trial NCT05572879
PMID 40881540Vaccine-Associated Proteinase 3 Anti-neutrophil Cytoplasmic Antibodies (PR3-ANCA) Vasculitis: A Case Report and Review of Emerging Evidence.Cureus2025name in abstract: ChAdOx1 nCoV-19
PMID 40896618An Unusual Glomerulopathy with Subepithelial Deposits Having Microspherular Structures Following COVID-19 Vaccine.Indian journal of nephrology2025name in abstract: ChAdOx1 nCoV-19
PMID 40974737Safety and immunogenicity of SpiN-Tec, a T-cell based RBD-Nucleocapsid chimeric vaccine for COVID-19.Vaccine2025name in abstract: Covishield
PMID 41101087A statistical method for evaluating vaccine-induced immune correlates of protection against infection and disease progression: application to the ChAdOx1-S nCoV-19 phase 3 trial.Vaccine2025name in abstract: ChAdOx1 nCoV-19
PMID 41196011T-cell responses to SARS-CoV-2 vaccinations in adults with Down syndrome - a prospective cohort study.Human vaccines & immunotherapeutics2025cited by trial NCT05145348
PMID 41239286Long-term trends in reporting of cardiac adverse drug reactions to COVID-19 vaccines - an exploratory analysis of the EudraVigilance database.BMC infectious diseases2025name in abstract: Vaxzevria
PMID 41295486Third Booster Half Dose of ChAdOx1-nCov-19 Is Effective, Safe, and Induces Long-Duration Humoral and Cellular Immune Response to Omicron: 1-Year Follow-Up of Viana Study.Vaccines2025cited by trial NCT05059106
PMID 41333456Immunogenicity and safety to SARS-Cov-2 vaccination in patients with systemic vasculitis.Frontiers in immunology2025name in abstract: ChAdOx1 nCoV-19
PMID 41409965A Rare Side Effect of Vaccine-Induced Thyrotoxicosis: A Case Report.Cureus2025name in abstract: ChAdOx1 nCoV-19
PMID 37291775Effect of COVID-19 Vaccination on Menstrual Cycle Patterns of Reproductive-age Women: A Multi-centric Observational Study.Current drug research reviews2024name in abstract: Covishield
PMID 37848232Fulminant Vaccine-Induced Immune Thrombotic Thrombocytopenia After ChAdOx1 nCoV-19 (AZD1222) Vaccine Administration in a Woman With Obesity: A Case Report.Acta neurologica Taiwanica2024name in title: ChAdOx1 nCoV-19
PMID 38157699Immune-mediated diseases after vaccinations with AZD1222, BNT-162b2, &/or mRNA-1273: An observational investigation of 78 patients.International immunopharmacology2024name in title: AZD1222
PMID 38206168SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines.Human vaccines & immunotherapeutics2024name in abstract: Vaxzevria
PMID 38280060Humoral and cellular immune response in patients of liver cirrhosis and immunocompetent recipient of ChAdOx1nCoV-19 Vaccine (Covishield).Clinical and experimental medicine2024name in title: ChAdOx1 nCoV-19
PMID 38295401Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan.Emerging infectious diseases2024name in abstract: AZD1222
PMID 38350771Acute disseminated encephalomyelitis and transverse myelitis following COVID-19 vaccination - A self-controlled case series analysis.Vaccine2024name in abstract: ChAdOx1 nCoV-19
PMID 38355209Bilateral non-arteritic posterior ischaemic optic neuropathy following COVID-19 vaccination.BMJ case reports2024name in abstract: ChAdOx1 nCoV-19
PMID 38395721Audiovestibular adverse events following COVID-19 vaccinations.Vaccine2024name in abstract: Vaxzevria
PMID 38465101Sporadic Kaposi Sarcoma Following a COVID-19 Vaccine: Mere Coincidence or Something More?Cureus2024name in abstract: ChAdOx1 nCoV-19
PMID 38482327Lichen planus triggered by COVID-19 vaccination: A case series.Journal of family medicine and primary care2024name in abstract: Covishield
PMID 38512394Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.Human vaccines & immunotherapeutics2024name in title: ChAdOx1 nCoV-19
PMID 38529033Probable secondary hemophagocytic lymphohistiocytosis manifesting as central nervous system lesions after COVID-19 vaccination: a case report.Frontiers in neurology2024name in abstract: ChAdOx1 nCoV-19
PMID 38544683Lower Motor Neuron Facial Palsy Following COVID-19 Infection and COVID-19 AZD1222 Vaxzervria (AstraZeneca) Vaccine Administration: Two Case Reports.International medical case reports journal2024name in title: AZD1222
PMID 38578809Effectiveness of ChAdOx1 nCoV-19 and BBIBP-CorV vaccines against COVID-19-associated hospitalisation and death in the Seychelles infected adult population.PloS one2024name in title: ChAdOx1 nCoV-19
PMID 38628985Pityriasis Rosea Eruption Following the Administration of Oxford-AstraZeneca Vaccine.Cureus2024name in abstract: AZD1222
PMID 38637636An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.Nature medicine2024name in abstract: ChAdOx1 nCoV-19
PMID 38643547Estimating vaccine efficacy during open-label follow-up of COVID-19 vaccine trials based on population-level surveillance data.Epidemics2024cited by trial NCT04516746
PMID 38649734Multi-omics analysis reveals COVID-19 vaccine induced attenuation of inflammatory responses during breakthrough disease.Nature communications2024name in abstract: ChAdOx1 nCoV-19
PMID 38684712A phase 3 randomized controlled trial of a COVID-19 recombinant vaccine S-268019-b versus ChAdOx1 nCoV-19 in Japanese adults.Scientific reports2024name in title: ChAdOx1 nCoV-19
PMID 38711707Guillain-Barré Syndrome After a SARS-CoV-2 Vaccine.Cureus2024name in abstract: AZD1222
PMID 38736760Thrombosis With Thrombocytopenia and Post-COVID-Vaccination Syndrome With Anti-G-Protein-Coupled Receptor (GPCR) Antibodies Treated With Therapeutic Plasma Exchange.Cureus2024name in abstract: Vaxzevria
PMID 38781552Effect of Corticosteroid on Immunogenicity of SARS-CoV-2 Vaccines in Patients With Solid Cancer.JCO global oncology2024name in abstract: ChAdOx1 nCoV-19
PMID 38827749Seasonal human coronavirus humoral responses in AZD1222 (ChaAdOx1 nCoV-19) COVID-19 vaccinated adults reveal limited cross-immunity.Frontiers in immunology2024cited by trial NCT04516746
PMID 38878794Immunogenicity and safety of beta variant COVID-19 vaccine AZD2816 and AZD1222 (ChAdOx1 nCoV-19) as primary-series vaccination for previously unvaccinated adults in Brazil, South Africa, Poland, and the UK: a randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study.The Lancet. Microbe2024cited by trial NCT04973449
PMID 38947434Disseminated herpes zoster with varicella encephalitis and pneumonia following ChAdOx1 nCoV-19 (AZD1222) vaccine in an immunocompetent male-a case report.Heliyon2024name in title: ChAdOx1 nCoV-19
PMID 38948557COVID-19 vaccine: Culprit or innocent bystander in a rare adverse gastro-intestinal surgical event? A case report with review of literature.Journal of family medicine and primary care2024name in abstract: Covishield
PMID 38958922Acquired immune thrombotic thrombocytopenic purpura (TTP) associated with inactivated COVID-19 vaccine CoronaVac.Frontiers of medicine2024name in abstract: ChAdOx1 nCoV-19
PMID 39060202Implementation and adherence to regular asymptomatic testing in a COVID-19 vaccine trial.Vaccine2024name in abstract: ChAdOx1 nCoV-19
PMID 39087341Suspected Vaccine-Associated Hypophysitis With Central Diabetes Insipidus After AZD1222 SARS-CoV-2 Vaccination.Deutsches Arzteblatt international2024name in title: AZD1222
PMID 39109140Integrated Approach to Severe Dengue Complicated by Guillain-Barré Syndrome and Multi-organ Failure.Cureus2024name in abstract: Covishield
PMID 39222525Herpes zoster triggered by ChAdOx1 nCoV-19 coronavirus vaccine (recombinant).The National medical journal of India2024name in title: ChAdOx1 nCoV-19
PMID 39222526Haemophagocytic lymphohistiocytosis post-ChAdOx1 nCoV-19 vaccine: A rare case.The National medical journal of India2024name in title: ChAdOx1 nCoV-19
PMID 39224589Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study.Frontiers in immunology2024name in abstract: AZD1222
PMID 39225478Association Between SARS-CoV-2 Viral Load and COVID-19 Vaccination in 4 Phase 3 Trials.The Journal of infectious diseases2024cited by trial NCT04516746
PMID 39286494Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants.iScience2024cited by trial NCT05378191
PMID 39318203Interim safety and immunogenicity analysis of the EuCorVac-19 COVID-19 vaccine in a Phase 3 randomized, observer-blind, immunobridging trial in the Philippines.Journal of medical virology2024cited by trial NCT05572879
PMID 39318737Chronic Immune Thrombocytopenia Purpura Following COVID-19 Vaccination (ChAdOx1 -nCov-19): A Case Report With OneYear Follow-Up.Hospital pharmacy2024name in title: ChAdOx1 nCoV-19
PMID 39341401The Platform Trial In COVID-19 Priming and BOOsting (PICOBOO): The immunogenicity, reactogenicity, and safety of different COVID-19 vaccinations administered as a second booster (fourth dose) in AZD1222 primed individuals aged 50-<70 years old.The Journal of infection2024name in title: AZD1222
PMID 39417469[Effect of previous exposure to COVID-19, occurrence of spikes, and type of vaccine on the humoral immune response of institutionalized older adults].Cadernos de saude publica2024name in abstract: AZD1222
PMID 39460334Kaposi Sarcoma as a Possible Cutaneous Adverse Effect of ChAdOx1 nCov-19 Vaccine: A Case Report.Vaccines2024name in title: ChAdOx1 nCoV-19
PMID 39482706The Platform trial In COVID-19 vaccine priming and BOOsting (PICOBOO) booster vaccination substudy protocol.Trials2024name in abstract: AZD1222
PMID 39551718Greater preservation of SARS-CoV-2 neutralising antibody responses following the ChAdOx1-S (AZD1222) vaccine compared with mRNA vaccines in haematopoietic cell transplant recipients.British journal of haematology2024name in title: AZD1222
PMID 39571084[Events attributable to Vaxzevria vaccine in pregnant women from a first-level hospital in Puebla].Revista medica del Instituto Mexicano del Seguro Social2024name in title: Vaxzevria
PMID 39584643[Post-Vaccination Adverse Events Related To The Administration Of The Covishield® Coronavirus Vaccine In Vaccinated Volunteers At The Bamako Dermatology Hospital From April To June 2021].Le Mali medical2024name in title: Covishield
PMID 39691001Post ChAdOx1 nCoV-19 Corona Virus Vaccine (Recombinant) (Covishield) Brachial Plexitis - Report of Two Cases Along with Review of Literature.Neurology India2024name in title: ChAdOx1 nCoV-19
PMID 39713602New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination.SAGE open medical case reports2024name in title: Vaxzevria
PMID 40729266Aggressive Vaccine-Induced Immune Thrombocytopenia and Thrombosis in a Young Woman with a Past Mild SARS-CoV-2 Infection.Reports (MDPI)2024name in abstract: ChAdOx1 nCoV-19
PMID 34890294Aortic thrombosis and acute limb ischemia after ChAdOx1 nCov-19 (Oxford-AstraZeneca) vaccination: a case of vaccine-induced thrombocytopenia and thrombosis (VITT).Acta chirurgica Belgica2023name in title: ChAdOx1 nCoV-19
PMID 35427250New-Onset Myasthenia Gravis After ChAdOx1 nCOV-19 Vaccine Inoculation.Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society2023name in title: ChAdOx1 nCoV-19
PMID 35484818Spontaneous suprachoroidal haemorrhage in haemophilia coincident with ChAdOx1 nCoV-19 vaccine.European journal of ophthalmology2023name in title: ChAdOx1 nCoV-19
PMID 35605819Serological response to vaccines against SARS-CoV-2 in patients with inflammatory bowel disease.Gastroenterologia y hepatologia2023name in abstract: Vaxzevria
PMID 35699073Waning humoral immunity of SARS-CoV-2 vaccination in a rheumatoid arthritis cohort and the benefits of a vaccine booster dose.Clinical and experimental rheumatology2023name in abstract: ChAdOx1 nCoV-19
PMID 35914285Possible Association between Vogt-Koyanagi-Harada Disease and Coronavirus Disease Vaccine: A Report of Four Cases.Ocular immunology and inflammation2023name in abstract: ChAdOx1 nCoV-19
PMID 35927820Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study.Current drug safety2023name in title: ChAdOx1 nCoV-19
PMID 35979616Multisystem Inflammatory Syndrome in Adults (MIS-A) After COVID-19 Infection and Recent Vaccination with Recombinant Adenoviral Vector Encoding the Spike Protein Antigen of SARS-CoV-2 (ChAdOx1 nCoV-19, Vaxzevria).Journal of intensive care medicine2023name in title: ChAdOx1 nCoV-19
PMID 36057889Case reports of management of aplastic anemia after COVID-19 vaccination: a single institute experience in Taiwan.International journal of hematology2023name in abstract: ChAdOx1 nCoV-19
PMID 36062592Branch retinal vein occlusion following ChAdOx1 nCoV-19 (Oxford-AstraZeneca) vaccine.European journal of ophthalmology2023name in title: ChAdOx1 nCoV-19
PMID 36156752Antibody Response and Safety of ChAdOx1-nCOV (Covishield) in Patients with Cirrhosis: A Cross-Sectional, Observational Study.Digestive diseases and sciences2023name in title: Covishield
PMID 36244851Molecular epidemiology of SARS-CoV-2 in healthcare workers and identification of viral genomic correlates of transmissibility and vaccine break through infection: A retrospective observational study from a cancer hospital in eastern India.Indian journal of medical microbiology2023name in abstract: ChAdOx1 nCoV-19
PMID 36256905Bilateral Atypical Optic Neuritis following ChAdOx1_nCoV-19 Vaccination: A Putative Plausibility.Ocular immunology and inflammation2023name in title: ChAdOx1 nCoV-19
PMID 36273491Durability of ChAdOx1 nCoV-19 (AZD1222) vaccine and hybrid humoral immunity against variants including omicron BA.1 and BA.4 6 months after vaccination (COV005): a post-hoc analysis of a randomised, phase 1b-2a trial.The Lancet. Infectious diseases2023cited by trial NCT04444674
PMID 36289074Postmortem PF4 antibodies confirm a rare case of thrombosis thrombocytopenia syndrome associated with ChAdOx1 nCoV-19 anti-COVID vaccination.International journal of legal medicine2023name in title: ChAdOx1 nCoV-19
PMID 36306426A Curious Case of Occlusive Retinal Vasculitis in a Young Individual Associated with COVID-19 Vaccination.Ocular immunology and inflammation2023name in abstract: Covishield
PMID 36342000Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report.American journal of kidney diseases : the official journal of the National Kidney Foundation2023name in abstract: ChAdOx1 nCoV-19
PMID 36367167The Association of Time of Day of ChAdOx1 nCoV-19 Vaccine Administration With SARS-CoV-2 Anti-Spike IgG Antibody Levels: An Exploratory Observational Study.Journal of biological rhythms2023name in title: ChAdOx1 nCoV-19
PMID 36398559Guillain-Barré syndrome after COVID-19 vaccines: A Tunisian case series.British journal of clinical pharmacology2023name in abstract: ChAdOx1 nCoV-19
PMID 36404171An evaluation of the safety and immunogenicity of MVC-COV1901: Results of an interim analysis of a phase III, parallel group, randomized, double-blind, active-controlled immunobridging study in Paraguay.Vaccine2023name in abstract: AZD1222
PMID 36435633Nasal vaccines: solutions for respiratory infectious diseases.Trends in molecular medicine2023cited by trial NCT04816019
PMID 36476455T-cell responses induced by ChAdOx1 nCoV-19 (AZD1222) vaccine to wild-type severe acute respiratory syndrome coronavirus 2 among people with and without HIV in South Africa.AIDS (London, England)2023name in title: ChAdOx1 nCoV-19
PMID 36610390AZD1222-induced nasal antibody responses are shaped by prior SARS-CoV-2 infection and correlate with virologic outcomes in breakthrough infection.Cell reports. Medicine2023cited by trial NCT04516746
PMID 36676781Non-Hodgkin Lymphoma Developed Shortly after mRNA COVID-19 Vaccination: Report of a Case and Review of the Literature.Medicina (Kaunas, Lithuania)2023name in abstract: ChAdOx1 nCoV-19
PMID 36682680Immunogenicity of a fractional or full third dose of AZD1222 vaccine or BNT162b2 messenger RNA vaccine after two doses of CoronaVac vaccines against the Delta and Omicron variants.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023name in title: AZD1222
PMID 36722847Adhesive Capsulitis After COVID-19 Vaccination: A Case Series.American journal of physical medicine & rehabilitation2023name in abstract: ChAdOx1 nCoV-19
PMID 36727385Acute bilateral central serous chorioretinopathy in a young male after the first dose of Oxford/AstraZeneca AZD1222 (Covishield) vaccine.Indian journal of ophthalmology2023name in title: Covishield
PMID 36739547[COVID-19 infections and effectiveness of the vaccination among healthcare workers].Orvosi hetilap2023name in abstract: ChAdOx1 nCoV-19
PMID 36754672Immune-mediated necrotizing myopathy following vaccination with the AstraZeneca (AZD1222) COVID-19 vaccine: A case report and brief review.Revue neurologique2023name in title: AZD1222
PMID 36754764A heterologous AZD1222 priming and BNT162b2 boosting regimen more efficiently elicits neutralizing antibodies, but not memory T cells, than the homologous BNT162b2 regimen.Vaccine2023name in title: AZD1222
PMID 36775731Vogt-Koyanagi-Harada disease following ChAdOx1 nCoV-19 and mRNA-1273 vaccination.Journal francais d'ophtalmologie2023name in title: ChAdOx1 nCoV-19
PMID 36800613Microsurgical complication associated with vaccine-induced immune thrombotic thrombocytopenia (VITT): A case report.Medicine2023name in abstract: ChAdOx1 nCoV-19
PMID 36821802Difference in Immunogenic Responses to COVID-19 Vaccines in Patients With Cancer Receiving Chemotherapy Versus Nonchemotherapy Treatment.JCO global oncology2023name in abstract: ChAdOx1 nCoV-19
PMID 36828523Concomitant Severe Psoriasis and Bullous Pemphigoid Induced by COVID-19.Tropical medicine and infectious disease2023name in abstract: AZD1222
PMID 36841502The effect of BCG vaccination on infection and antibody levels against SARS-CoV-2-The results of ProBCG: a multicenter randomized clinical trial in Brazil.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023name in abstract: Covishield
PMID 36851662Longitudinal IgA and IgG Response, and ACE2 Binding Blockade, to Full-Length SARS-CoV-2 Spike Protein Variants in a Population of Black PLWH Vaccinated with ChAdOx1 nCoV-19.Viruses2023cited by trial NCT04444674
PMID 36855108Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19.BMC medicine2023name in title: ChAdOx1 nCoV-19
PMID 36861579Post-Vaccination/Post-COVID Immune-Mediated Demyelination of the Brain and Spinal Cord: A Novel Neuroimaging Finding.Neurology India2023name in abstract: ChAdOx1 nCoV-19
PMID 36870745COVID-19 patients' clinical profile and outcome with respect to their vaccination status: A prospective observational multicentre cohort study during third wave in Western India.Indian journal of medical microbiology2023name in abstract: Covishield
PMID 36889512Effect of calcifediol supplementation as add-on therapy on the immune repertoire in recipients of the ChAdOx1 nCoV-19 vaccine: A prospective open-label, placebo-controlled, clinical trial.The Journal of infection2023name in title: ChAdOx1 nCoV-19
PMID 36919452Effects of COVID-19 vaccine type on Guillain-Barré syndrome: Two cases and a literature review.Human vaccines & immunotherapeutics2023name in abstract: ChAdOx1 nCoV-19
PMID 36932639Thrombosis with Thrombocytopenia Syndrome (TTS) After ChAdOx1 nCoV-19 Immunization: An Investigative Case Report.The American journal of case reports2023name in title: ChAdOx1 nCoV-19
PMID 36984555Mucormycosis in a Patient with Severe COVID-19 Disease-The First Case Report in Romania and a Literature Review.Medicina (Kaunas, Lithuania)2023name in abstract: Vaxzevria
PMID 37007264A rare case of bilateral optic neuritis post-Covishield (ChAdOx1-S [recombinant]) vaccination.Oman journal of ophthalmology2023name in title: Covishield
PMID 37012199Sequential provocation of Ekbom's syndrome and acute mania following AstraZeneca COVID-19 vaccination.Asian journal of psychiatry2023name in abstract: ChAdOx1 nCoV-19
PMID 37028454Persistence of immune response in heterologous COVID vaccination schedules in the Com-COV2 study - A single-blind, randomised trial incorporating mRNA, viral-vector and protein-adjuvant vaccines.The Journal of infection2023name in abstract: ChAdOx1 nCoV-19
PMID 37029003Acute reactions after a homologous primary COVID-19 vaccination series: Analysis of Taiwan V-Watch data.Vaccine2023name in abstract: ChAdOx1 nCoV-19
PMID 37038568Inflammatory Arthritis Associated with COVID-19 Vaccination.Cureus2023name in abstract: Vaxzevria
PMID 37038643COVID-19 Vaccine-Associated Pneumonitis in the Republic of Korea: A Nationwide Multicenter Survey.Journal of Korean medical science2023name in abstract: ChAdOx1 nCoV-19
PMID 37043615Multiple Evanescent White Dot Syndrome Following Adenovirus Vector-Based COVID-19 Vaccine (Covishield).Ocular immunology and inflammation2023name in title: Covishield
PMID 37052679A third vaccine dose equalises the levels of effectiveness and immunogenicity of heterologous or homologous COVID-19 vaccine regimens, Lyon, France, December 2021 to March 2022.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2023name in abstract: Vaxzevria
PMID 37077469Cerebral venous sinus thrombosis following ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine.JRSM cardiovascular disease2023name in title: ChAdOx1 nCoV-19
PMID 37080829Safety and immunogenicity of homologous versus heterologous booster dose with AZD1222, mRNA-1273, or MVC-COV1901 SARS-CoV-2 vaccines in adults: An observer-blinded, multi-center, phase 2 randomized trial.Vaccine2023cited by trial NCT05197153
PMID 37085049Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.The Journal of infection2023name in abstract: ChAdOx1 nCoV-19
PMID 37087559Kidney Transplantation from a Deceased Donor with COVID-19 Ad26.COV2-S Vaccine-Induced Thrombotic Thrombocytopenia.The American journal of case reports2023name in abstract: ChAdOx1 nCoV-19
PMID 37090999New acute onset of ocular myasthenia gravis after COVID-19 vaccine: A case report.Journal of family medicine and primary care2023name in abstract: Covishield
PMID 37095378High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity.Nature immunology2023cited by trial NCT04988048
PMID 37113012Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial.Human vaccines & immunotherapeutics2023name in title: ChAdOx1 nCoV-19
PMID 37133805Long-Term Safety Analysis of the ChAdOx1-nCoV-19 Corona Virus Vaccine: Results from a Prospective Observational Study in Priority Vaccinated Groups in North India.Drug safety2023name in title: ChAdOx1 nCoV-19
PMID 37138460The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines.Human vaccines & immunotherapeutics2023cited by trial NCT04324606
PMID 37148041Spectrum of Serious Neurological and Psychiatric Adverse Events in Indian COVID-19 Vaccine Recipients: A Systematic Review of Case Reports and Case Series.Neurology India2023name in abstract: Covishield
PMID 37149443Efficacy of primary series AZD1222 (ChAdOx1 nCoV-19) vaccination against SARS-CoV-2 variants of concern: Final analysis of a randomized, placebo-controlled, phase 1b/2 study in South African adults (COV005).Vaccine2023cited by trial NCT04444674
PMID 37198509A case with prolonged headache after COVID-19 vaccination and later developed Bell's palsy.Acta neurologica Taiwanica2023name in abstract: ChAdOx1 nCoV-19
PMID 37202971Acute abducens nerve palsy with acute disseminated encephalomyelitis-like presentation following COVID-19 vaccination.Indian journal of ophthalmology2023name in abstract: Covishield
PMID 37214181Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report.IDCases2023name in title: ChAdOx1 nCoV-19
PMID 37260728Deep vein thrombosis as thrombotic sequelae of vaccine-induced thrombotic thrombocytopenia.Oxford medical case reports2023name in abstract: ChAdOx1 nCoV-19
PMID 37266107Cutaneous Adverse Drug Reactions (CADRs) to COVID19 Vaccines: A Case Series.Indian dermatology online journal2023name in abstract: Covishield
PMID 37271703One year safety and immunogenicity of AZD1222 (ChAdOx1 nCoV-19): Final analysis of a randomized, placebo-controlled phase 1/2 trial in Japan.Vaccine2023cited by trial NCT04568031
PMID 37303102[Cryptogenic new-onset super-refractory status epilepticus following SARS-CoV-2 vaccination. A case report].Revista de neurologia2023name in abstract: ChAdOx1 nCoV-19
PMID 37305866Covishield vaccination and pulmonary thromboembolism: A coincidence or a causal association?Clinical case reports2023name in title: Covishield
PMID 37322634Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & omicron SARS-CoV-2 infection: Implications for boosting.The Indian journal of medical research2023name in abstract: ChAdOx1 nCoV-19
PMID 37331336Adverse Effects of COVID-19 Vaccination in Patients with Transfusion-Dependent Thalassemia: An Observational Study from a Tertiary Care Center in Punjab, India.Acta haematologica2023name in abstract: Covishield
PMID 37351283A case report of vaccine-induced immune thrombotic thrombocytopenia (VITT) with genetic analysis.Frontiers in cardiovascular medicine2023name in abstract: ChAdOx1 nCoV-19
PMID 37357073Characterization of immune responses to two and three doses of the adenoviral vectored vaccine ChAdOx1 nCov-19 and the whole virion inactivated vaccine BBV152 in a mix-and-match study in India.Vaccine2023name in title: ChAdOx1 nCoV-19
PMID 37360926An unusual case of acquired aplastic anemia following SARS-CoV-2 vaccination: A case report.IDCases2023name in abstract: Covishield
PMID 37364205ACUTE MACULAR NEURORETINOPATHY FOLLOWING SARS-CoV-2 VACCINATION.Retinal cases & brief reports2023name in abstract: Vaxzevria
PMID 37376504Vaccine-Induced Immune Thrombotic Thrombocytopenia following BNT162b2 mRNA COVID-19 Booster: A Case Report.Vaccines2023name in abstract: ChAdOx1 nCoV-19
PMID 37385888Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials.Vaccine2023cited by trial NCT04516746
PMID 37406777Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial.The Journal of infection2023cited by trial NCT04864561
PMID 37417024Outcome of COVID-19 infection and the impact of COVID-19 vaccination in chronic kidney disease patients: A single-center study.Annals of African medicine2023name in abstract: Covishield
PMID 37439701Superior Boosting of Neutralizing Titers Against Omicron SARS-CoV-2 Variants by Heterologous SCB-2019 Vaccine vs a Homologous Booster in CoronaVac-Primed Adults.The Journal of infectious diseases2023cited by trial NCT05188677
PMID 37481764Elevated serum levels of T-cell immunoglobulin and mucin-domain containing molecule 3 in patients with systemic inflammation following COVID-19 vaccination.Journal of the Chinese Medical Association : JCMA2023name in abstract: ChAdOx1 nCoV-19
PMID 37485074Eculizumab discontinuation in a patient with atypical hemolytic uremic syndrome after ChAdOx1 nCoV-19 vaccination.Clinical nephrology. Case studies2023name in title: ChAdOx1 nCoV-19
PMID 37534447Risk reduction analysis of mix-and-match vaccination strategy in healthcare workers during SARS-CoV-2 Omicron variant predominant period: A multi-center cohort study in Taiwan.Human vaccines & immunotherapeutics2023name in abstract: ChAdOx1 nCoV-19
PMID 37655367Thromboembolism after Astra Zeneca COVID-19 vaccine: Not always PF4- antibody mediated.Human vaccines & immunotherapeutics2023name in abstract: AZD1222
PMID 37692635Reverse Takotsubo Cardiomyopathy Following COVISHIELD Vaccination: A Rare Case of an Anaphylactic Reaction.Cureus2023name in title: Covishield
PMID 37731681Dynamic Antibody Response and Hybrid Immunity Following Multiple COVID-19 Vaccine Doses and Infection: A Case Study.Cureus2023name in abstract: AZD1222
PMID 37767414Quadriparesis with different diagnoses after COVID-19 vaccination: Case series and literature review.Journal of family medicine and primary care2023name in abstract: ChAdOx1 nCoV-19
PMID 37773791Antibody response in patients undergoing chronic hemodialysis post-severe acute respiratory syndrome coronavirus 2 vaccination: A prospective observational study.Medicine2023name in abstract: ChAdOx1 nCoV-19
PMID 37783221Immunogenicity and safety of AZD2816, a beta (B.1.351) variant COVID-19 vaccine, and AZD1222 (ChAdOx1 nCoV-19) as third-dose boosters for previously vaccinated adults: a multicentre, randomised, partly double-blinded, phase 2/3 non-inferiority immunobridging study in the UK and Poland.The Lancet. Microbe2023cited by trial NCT04973449
PMID 37789040A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.Scientific reports2023name in abstract: ChAdOx1 nCoV-19
PMID 37867584Guillain-Barré Syndrome Post COVID-19 Vaccination with ChAdOx1 nCoV-19 Vaccine: A Colombian Case Report.Case reports in infectious diseases2023name in title: ChAdOx1 nCoV-19
PMID 37903679Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines.Vaccine2023cited by trial NCT05110911
PMID 37942375Autoimmune Hemolytic Anemia Secondary to COVID-19 Vaccine: A Case Report.Cureus2023name in abstract: Covishield
PMID 38061717A Generalized Lichen Planus Following COVID-19 Vaccination: A Case Report.Annals of dermatology2023name in abstract: AZD1222
PMID 38098118COVISHIELD vaccine-induced thyroiditis: a case report.Journal of medical case reports2023name in title: Covishield
PMID 38310417Anti-N-methyl D-aspartate Receptor Encephalitis Following ChAdOx1 nCoV-19 Vaccination: A Case Report.Archives of Iranian medicine2023name in title: ChAdOx1 nCoV-19
PMID 34216472An Observational Cohort Study on the Incidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and B.1.1.7 Variant Infection in Healthcare Workers by Antibody and Vaccination Status.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America2022name in abstract: ChAdOx1 nCoV-19
PMID 34261746Bilateral facial weakness with paraesthesia variant of Guillain-Barré syndrome following Vaxzevria COVID-19 vaccine.Journal of neurology, neurosurgery, and psychiatry2022name in title: Vaxzevria
PMID 34406660Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination.Journal of medical virology2022name in title: ChAdOx1 nCoV-19
PMID 34420802[Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19].Medicina intensiva2022name in title: ChAdOx1 nCoV-19
PMID 34482558Generalized bullous fixed drug eruption after Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccination.Clinical and experimental dermatology2022name in title: ChAdOx1 nCoV-19
PMID 34483267ChAdOx1 nCoV-19 vaccine-associated thrombocytopenia: three cases of immune thrombocytopenia after 107 720 doses of ChAdOx1 vaccination in Thailand.Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis2022name in title: ChAdOx1 nCoV-19
PMID 34491572Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): A preliminary analysis from north India.Journal of medical virology2022name in title: ChAdOx1 nCoV-19
PMID 34590902ADEM after ChAdOx1 nCoV-19 vaccine: A case report.Multiple sclerosis (Houndmills, Basingstoke, England)2022name in title: ChAdOx1 nCoV-19
PMID 34672380Refractory vaccine-induced immune thrombotic thrombocytopenia (VITT) managed with delayed therapeutic plasma exchange (TPE).Journal of clinical apheresis2022name in abstract: ChAdOx1 nCoV-19
PMID 34688944Immunogenicity and safety of AZD1222 (ChAdOx1 nCoV-19) against SARS-CoV-2 in Japan: a double-blind, randomized controlled phase 1/2 trial.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022cited by trial NCT04568031
PMID 34702598A Case Report of Posttransplant Lymphoproliferative Disorder After AstraZeneca Coronavirus Disease 2019 Vaccine in a Heart Transplant Recipient.Transplantation proceedings2022name in abstract: ChAdOx1 nCoV-19
PMID 34724668Atypical Hemolytic Uremic Syndrome after ChAdOx1 nCoV-19 Vaccination in a Patient with Homozygous CFHR3/CFHR1 Gene Deletion.Nephron2022name in title: ChAdOx1 nCoV-19
PMID 34726187Cutaneous Lymphocytic Vasculitis After Administration of the Second Dose of AZD1222 (Oxford-AstraZeneca) Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination: Casuality or Causality?The American Journal of dermatopathology2022name in title: AZD1222
PMID 34731529Erythema annulare centrifugum induced by COVID-19 vaccination.Clinical and experimental dermatology2022name in abstract: AZD1222
PMID 34751259Safety and immunogenicity of ChAdOx1 MERS vaccine candidate in healthy Middle Eastern adults (MERS002): an open-label, non-randomised, dose-escalation, phase 1b trial.The Lancet. Microbe2022name in abstract: ChAdOx1 nCoV-19
PMID 34751429A case of toxic epidermal necrolysis after ChAdOx1 nCov-19 (AZD1222) vaccination.The Australasian journal of dermatology2022name in title: ChAdOx1 nCoV-19
PMID 34768287Red urine and a red herring - diagnosing rare diseases in the light of the COVID-19 pandemic.Zeitschrift fur Gastroenterologie2022name in abstract: ChAdOx1 nCoV-19
PMID 34782400Endovascular treatment for vaccine-induced cerebral venous sinus thrombosis and thrombocytopenia following ChAdOx1 nCoV-19 vaccination: a report of three cases.Journal of neurointerventional surgery2022name in title: ChAdOx1 nCoV-19
PMID 34794199Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2.Thrombosis and haemostasis2022name in title: ChAdOx1 nCoV-19
PMID 34797392A flare of Still's disease following COVID-19 vaccination in a 34-year-old patient.Rheumatology international2022name in abstract: ChAdOx1 nCoV-19
PMID 34838783Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary-the HUN-VE study.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022name in abstract: AZD1222
PMID 34849183Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine.Radiology case reports2022name in abstract: AZD1222
PMID 34862126Antibody response to COVID-19 vaccine: A point of view that can help to optimize dose distribution.International immunopharmacology2022name in abstract: Vaxzevria
PMID 34883053Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.Lancet (London, England)2022name in abstract: ChAdOx1 nCoV-19
PMID 34895938SARS-CoV-2-antibody response in health care workers after vaccination or natural infection in a longitudinal observational study.Vaccine2022name in abstract: Vaxzevria
PMID 34929493Heterologous ChAdOx1 nCoV-19 and BNT162b2 prime-boost vaccination elicits potent neutralizing antibody responses and T cell reactivity against prevalent SARS-CoV-2 variants.EBioMedicine2022name in title: ChAdOx1 nCoV-19
PMID 34931927MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination.Multiple sclerosis (Houndmills, Basingstoke, England)2022name in title: ChAdOx1 nCoV-19
PMID 34937265Central retinal vein occlusion post-COVID-19 vaccination.Indian journal of ophthalmology2022name in abstract: Covishield
PMID 34937268Stromal rejection in penetrating keratoplasty following COVID-19 vector vaccine (Covishield) - A case report and review of literature.Indian journal of ophthalmology2022name in title: Covishield
PMID 34937269Harada-like syndrome post-Covishield vaccination: A rare adverse effect.Indian journal of ophthalmology2022name in title: Covishield
PMID 34954484Diabetic ketoacidosis (DKA) in type 1 diabetes mellitus (T1DM) temporally related to COVID-19 vaccination.Diabetes & metabolic syndrome2022name in abstract: ChAdOx1 nCoV-19
PMID 34955313Aseptic meningitis following AZD1222 COVID-19 vaccination.The American journal of emergency medicine2022name in title: AZD1222
PMID 34958931Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022name in title: ChAdOx1 nCoV-19
PMID 34962036L-lysine in herpesvirus reactivation after ChAdOx1 nCoV-19 vaccine (AZD1222): Minor literature review and case report.Dermatologic therapy2022name in title: ChAdOx1 nCoV-19
PMID 34967727Plasma exchange as an effective salvage therapy in AZD1222 vaccine-induced thrombotic thrombocytopenia: a case report.Blood transfusion = Trasfusione del sangue2022name in title: AZD1222
PMID 34973526Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination.Journal of autoimmunity2022name in abstract: Vaxzevria
PMID 34986294Effect of Covid-19 Vaccination on Transmission of Alpha and Delta Variants.The New England journal of medicine2022name in abstract: ChAdOx1 nCoV-19
PMID 34986404Vaccine-induced massive pulmonary embolism and thrombocytopenia following a single dose of Janssen Ad26.COV2.S vaccination.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022name in abstract: Vaxzevria
PMID 35001190Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022name in title: ChAdOx1 nCoV-19
PMID 35013724COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature.Journal of translational autoimmunity2022name in abstract: ChAdOx1 nCoV-19
PMID 35022931Arterial intracranial thrombosis as the first manifestation of vaccine-induced immune thrombotic thrombocytopenia (VITT): a case report.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2022name in abstract: ChAdOx1 nCoV-19
PMID 35027397Additional heterologous versus homologous booster vaccination in immunosuppressed patients without SARS-CoV-2 antibody seroconversion after primary mRNA vaccination: a randomised controlled trial.Annals of the rheumatic diseases2022name in abstract: ChAdOx1 nCoV-19
PMID 35042734Novel case of takotsubo cardiomyopathy following COVID-19 vaccination.BMJ case reports2022name in abstract: ChAdOx1 nCoV-19
PMID 35047227Anti-SARS-CoV-2 Antibody Level among Renal Transplant Recipients: A Case Report from Nepal.Case reports in urology2022name in abstract: AZD1222
PMID 35049004Ultrastructural findings of lung injury due to Vaccine-induced Immune Thrombotic Thrombo- cytopenia (VITT) following COVID-19 vaccination: a scanning electron microscopic study.European review for medical and pharmacological sciences2022name in abstract: ChAdOx1 nCoV-19
PMID 35050826Bilateral Sequential Acute Macular Neuroretinopathy in an Asian Indian Female with β Thalassemia Trait following (Corona Virus Disease) COVID-19 Vaccination and Probable Recent COVID Infection - Multimodal Imaging Study.Ocular immunology and inflammation2022name in abstract: Covishield
PMID 35050829Two Cases of Acute Macular Neuroretinopathy Associated with the Adenovirus-based COVID-19 Vaccine Vaxzevria (Astrazeneca).Ocular immunology and inflammation2022name in title: Vaxzevria
PMID 35062787Atypical Kawasaki Disease after COVID-19 Vaccination: A New Form of Adverse Event Following Immunization.Vaccines2022name in abstract: Vaxzevria
PMID 35065747Acute ST-Segment Elevation Myocardial Infarction After ChAdOx1 nCoV-19 Vaccination in a 33-Year-Old Man.Annals of emergency medicine2022name in title: ChAdOx1 nCoV-19
PMID 35069804MOG antibody-associated encephalomyelitis mimicking bacterial meningomyelitis following ChAdOx1 nCoV-19 vaccination: a case report.Therapeutic advances in neurological disorders2022name in title: ChAdOx1 nCoV-19
PMID 35071987Sub-acute Onset of Guillain-Barré Syndrome Post-mRNA-1273 Vaccination: a Case Report.SN comprehensive clinical medicine2022name in abstract: ChAdOx1 nCoV-19
PMID 35074136Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.Lancet (London, England)2022name in abstract: ChAdOx1 nCoV-19
PMID 35077038Coincidental Onset of Ocular Myasthenia Gravis Following ChAdOx1 n-CoV-19 Vaccine against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).The Israel Medical Association journal : IMAJ2022name in title: ChAdOx1 nCoV-19
PMID 35084719Humoral immunogenicity and tolerability of heterologous ChAd/BNT compared with homologous BNT/BNT and ChAd/ChAd SARS-CoV-2 vaccination in hemodialysis patients : A multicenter prospective observational study.Journal of nephrology2022name in abstract: ChAdOx1 nCoV-19
PMID 35086265Optic neuritis following COVID-19 vaccination: Coincidence or side-effect? - A case series.Indian journal of ophthalmology2022name in abstract: Covishield
PMID 35093626Late-Onset Vaccine-Induced Immune Thombotic Thrombocytopenia (VITT) with Cerebral Venous Sinus Thrombosis.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2022name in abstract: ChAdOx1 nCoV-19
PMID 35107123A public health perspective on the responsibility of mass media for the outcome of the anti-COVID-19 vaccination campaign: the AstraZeneca case.Annali di igiene : medicina preventiva e di comunita2022name in abstract: Vaxzevria
PMID 35110289Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination.BMJ case reports2022name in title: ChAdOx1 nCoV-19
PMID 35110645Immune responses following the first dose of the Sputnik V (Gam-COVID-Vac).Scientific reports2022name in abstract: AZD1222
PMID 35113750Bilateral Panuveitis Mimicking Vogt-Koyanagi-Harada Disease following the First Dose of ChAdOx1 nCoV-19 Vaccine.Ocular immunology and inflammation2022name in title: ChAdOx1 nCoV-19
PMID 35113987Most anti-PF4 antibodies in vaccine-induced immune thrombotic thrombocytopenia are transient.Blood2022name in abstract: ChAdOx1 nCoV-19
PMID 35123676COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study.The lancet. Gastroenterology & hepatology2022name in abstract: ChAdOx1 nCoV-19
PMID 35124800Interdependencies of cellular and humoral immune responses in heterologous and homologous SARS-CoV-2 vaccination.Allergy2022name in abstract: ChAdOx1 nCoV-19
PMID 35135453Active Symptom-Based Surveillance of Adverse Events Following Immunization Among Individuals Vaccinated with ChAdOx1 nCoV-19 Coronavirus Vaccine in a Tertiary Hospital of Kerala.Current drug safety2022name in title: ChAdOx1 nCoV-19
PMID 35136646Imaging findings in a patient with suspected vaccine induced immune thrombotic thrombocytopenia.BJR case reports2022name in abstract: ChAdOx1 nCoV-19
PMID 35144085Histological and immunohistochemical findings in a fatal case of thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination.Pathology, research and practice2022name in title: ChAdOx1 nCoV-19
PMID 35145690Serious events following COVID-19 vaccination with ChAdOx1 nCoV-19 vaccine (Vaxzevria): A short case series from Iran.Clinical case reports2022name in title: ChAdOx1 nCoV-19
PMID 35155043Neurological Conditions Following COVID-19 Vaccinations: Chance or Association?Cureus2022name in abstract: ChAdOx1 nCoV-19
PMID 35175717Acute Cardiac Events After ChAdOx1 nCoV-19 Corona Virus Vaccine: Report of Three Cases.American journal of therapeutics2022name in title: ChAdOx1 nCoV-19
PMID 35182759Reactogenicity among health care workers following a BNT162b2 or mRNA-1273 second dose after priming with a ChAdOx1 nCOV-19 vaccine.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022name in title: ChAdOx1 nCoV-19
PMID 35186534A Rare Case of Brachial Plexus Neuropraxia After COVID-19 Vaccination.Cureus2022name in abstract: Covishield
PMID 35186544Adult-Onset Still's Disease After the ChAdOx1 nCoV-19 Vaccine.Cureus2022name in title: ChAdOx1 nCoV-19
PMID 35189775A case of myocarditis following ChAdOx1 nCov-19 vaccination.Acta cardiologica2022name in title: ChAdOx1 nCoV-19
PMID 35192543Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV.JCI insight2022cited by trial NCT04400838
PMID 35196824The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study.Microbiology spectrum2022name in abstract: AZD1222
PMID 35207456Case Report of Cerebral Sinus Thrombosis Related to Immune Thrombotic Thrombocytopenia Following Administration of ChAdOx1 nCoV-19 for Vaccination against COVID-19.Life (Basel, Switzerland)2022name in title: ChAdOx1 nCoV-19
PMID 35210118Immunogenicity and safety of an intradermal fractional third dose of ChAdOx1 nCoV-19/AZD1222 vaccine compared with those of a standard intramuscular third dose in volunteers who previously received two doses of CoronaVac: A randomized controlled trial.Vaccine2022name in title: ChAdOx1 nCoV-19
PMID 35216789Newly diagnosed neuromyelitis optica spectrum disorders following vaccination: Case report and systematic review.Multiple sclerosis and related disorders2022name in abstract: ChAdOx1 nCoV-19
PMID 35218512Hemophagocytic lymphohistiocytosis after SARS-CoV-2 vaccination.Infection2022name in abstract: Vaxzevria
PMID 35220345Acute Vulvar Aphthous Ulceration After COVID-19 Vaccination: 3 Cases.Journal of lower genital tract disease2022name in abstract: ChAdOx1 nCoV-19
PMID 35223113Widespread Arterial Thrombosis after ChAdOx1 nCov-19 Vaccination.Case reports in critical care2022name in title: ChAdOx1 nCoV-19
PMID 35224056Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination.Frontiers in cardiovascular medicine2022name in title: ChAdOx1 nCoV-19
PMID 35241013Herpes simplex encephalitis following ChAdOx1 nCoV-19 vaccination: a case report and review of the literature.BMC infectious diseases2022name in title: ChAdOx1 nCoV-19
PMID 35247654Diffuse cutaneous systemic sclerosis following SARS-Co V-2 vaccination.Journal of autoimmunity2022name in abstract: ChAdOx1 nCoV-19
PMID 35249157Two flares of Still's disease after two doses of the ChAdOx1 vaccine.Clinical rheumatology2022name in abstract: ChAdOx1 nCoV-19
PMID 35274363Another case of generalized bullous fixed drug eruption following an adenoviral vector-based COVID-19 vaccine (ChAdOx1 nCov-19).Journal of the European Academy of Dermatology and Venereology : JEADV2022name in title: ChAdOx1 nCoV-19
PMID 35276381Adverse events following COVID-19 vaccination in South Korea between February 28 and August 21, 2021: A nationwide observational study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022name in abstract: AZD1222
PMID 35277439Stroke Among SARS-CoV-2 Vaccine Recipients in Mexico: A Nationwide Descriptive Study.Neurology2022name in abstract: ChAdOx1 nCoV-19
PMID 35277470Acute Calcium Pyrophosphate Crystal Arthritis of the Wrist Elicited by Anti-COVID-19 Vaccination After Carpal Tunnel Release.The American journal of case reports2022name in abstract: ChAdOx1 nCoV-19
PMID 35289136A Case Report of Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination and Heparin Use During Hemodialysis.Journal of Korean medical science2022name in title: ChAdOx1 nCoV-19
PMID 35299613MOG Antibody-Associated Disorders Following SARS-CoV-2 Vaccination: A Case Report and Literature Review.Frontiers in neurology2022name in abstract: ChAdOx1 nCoV-19
PMID 35305895Immune response and safety of heterologous ChAdOx1-nCoV-19/mRNA-1273 vaccination compared with homologous ChAdOx1-nCoV-19 or homologous mRNA-1273 vaccination.Journal of the Formosan Medical Association = Taiwan yi zhi2022cited by trial NCT05074368
PMID 35334625Fulminant Giant Cell Myocarditis following Heterologous Vaccination of ChAdOx1 nCoV-19 and Pfizer-BioNTech COVID-19.Medicina (Kaunas, Lithuania)2022name in title: ChAdOx1 nCoV-19
PMID 35341647A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines.Vaccine2022name in title: AZD1222
PMID 35348281Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature.Journal of cosmetic dermatology2022name in title: ChAdOx1 nCoV-19
PMID 35354570Vaccination-associated immune thrombocytopenia possibly due to ChAdOx1 nCoV-19 (Covishield) coronavirus vaccine.BMJ case reports2022name in title: ChAdOx1 nCoV-19
PMID 35371100Case Report: Severe Rhabdomyolysis and Multiorgan Failure After ChAdOx1 nCoV-19 Vaccination.Frontiers in immunology2022name in title: ChAdOx1 nCoV-19
PMID 35371725Subacute Thyroiditis After Severe Acute Respiratory Syndrome Coronavirus 2 Vaxzevria Vaccination in a Patient With Thyroid Autoimmunity.Cureus2022name in title: Vaxzevria
PMID 35380028A Case of Heart Transplantation for Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccination.Journal of Korean medical science2022name in title: ChAdOx1 nCoV-19
PMID 35381296Reversible neurological and brain MRI changes following COVID-19 vaccination: A case report.Journal of neuroradiology = Journal de neuroradiologie2022name in abstract: AZD1222
PMID 35394853Recurrent Anterior Non-necrotizing Scleritis as an Adverse Event of ChAdOx1 nCoV-19 (Vaxzevria) Vaccine.Ocular immunology and inflammation2022name in title: ChAdOx1 nCoV-19
PMID 35405168Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.The Journal of infection2022name in title: ChAdOx1 nCoV-19
PMID 35432314Humoral and Cellular Immunogenicity and Safety of Five Different SARS-CoV-2 Vaccines in Patients With Autoimmune Rheumatic and Musculoskeletal Diseases in Remission or With Low Disease Activity and in Healthy Controls: A Single Center Study.Frontiers in immunology2022name in abstract: AZD1222
PMID 35433058Site Injection Reaction, Maculopapular Rash, and Rosacea Exacerbation after COVID-19 Vaccination.Case reports in dermatological medicine2022name in abstract: AZD1222
PMID 35444919Myelin Oligodendrocyte Glycoprotein-Associated Disorders Post-ChAdOx1 Vaccination.Cureus2022name in abstract: ChAdOx1 nCoV-19
PMID 35449030Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: a longitudinal study.Genome medicine2022name in abstract: ChAdOx1 nCoV-19
PMID 35455352Delayed Cutaneous Adverse Reaction of the AstraZeneca COVID-19 Vaccine in a Breastfed Female Infant: A Coincidence or a Rare Effect?Vaccines2022name in abstract: ChAdOx1 nCoV-19
PMID 35459652Acute herpes zoster radiculopathy mimicking cervical radiculopathy after ChAdOx1 nCoV-19/AZD1222 vaccination.BMJ case reports2022name in title: ChAdOx1 nCoV-19
PMID 35465020Severe thrombocytopenia after Vaxzevria vaccination in a single patient: A case report.SAGE open medical case reports2022name in title: Vaxzevria
PMID 35472300Effectiveness of homologous and heterologous booster doses for an inactivated SARS-CoV-2 vaccine: a large-scale prospective cohort study.The Lancet. Global health2022name in abstract: AZD1222
PMID 35502082A case of acute endothelial corneal transplant rejection following immunization with ChAdOx1 nCoV-19 coronavirus vaccine.Indian journal of ophthalmology2022name in title: ChAdOx1 nCoV-19
PMID 35504460Covid19 vaccination-associated portal vein thrombosis-An interdisciplinary clinical challenge.Clinics and research in hepatology and gastroenterology2022name in abstract: ChAdOx1 nCoV-19
PMID 35510490Vocal fold paralysis following first dose of Oxford-AstraZeneca coronavirus disease 2019 vaccine.The Journal of laryngology and otology2022name in abstract: ChAdOx1 nCoV-19
PMID 35512906Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT).Seminars in hematology2022name in abstract: ChAdOx1 nCoV-19
PMID 35516695Post immunization COVID-19 disease.Journal of family medicine and primary care2022name in abstract: Covishield
PMID 35524323Superficial venous thrombosisas a possible consequence of ChAdOx1 nCoV-19 vaccine: two case reports.Journal of medical case reports2022name in title: ChAdOx1 nCoV-19
PMID 35528839Acute Fulminant Myocarditis After ChAdOx1 nCoV-19 Vaccine: A Case Report and Literature Review.Frontiers in cardiovascular medicine2022name in title: ChAdOx1 nCoV-19
PMID 35546097A case of adenoviral covid-19 vector vaccine possibly linked to severe but reversible interstitial lung injury post-vaccination.Infectious diseases (London, England)2022name in abstract: AZD1222
PMID 35550261Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial.The Lancet. Infectious diseases2022name in title: ChAdOx1 nCoV-19
PMID 35571584Local myofascitis of the deltoid muscle after administration of the AstraZeneca (AZD1222) COVID-19 vaccine: two cases, infectious and inflammatory.JSES reviews, reports, and techniques2022name in title: AZD1222
PMID 35572945Case Report: Acute Necrotizing Encephalopathy Following COVID-19 Vaccine.Frontiers in neurology2022name in abstract: ChAdOx1 nCoV-19
PMID 35579135Post COVID-19 Vaccination Acute Disseminated Encephalomyelitis: A Case Report.Current medical imaging2022name in abstract: ChAdOx1 nCoV-19
PMID 35580449Vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccine in an older patient: Minireview and a case report.Journal of infection and public health2022name in title: ChAdOx1 nCoV-19
PMID 35587646Herpes simplex virus retinitis following ChAdOx1 nCoV- 19 (Covishield) vaccination for SARS CoV 2: A case report.Ocular immunology and inflammation2022name in title: ChAdOx1 nCoV-19
PMID 35599706Vaccine-induced prothrombotic immune thrombocytopenia without thrombosis may not require immune modulatory therapy: A case report.Research and practice in thrombosis and haemostasis2022name in abstract: ChAdOx1 nCoV-19
PMID 35613221Facial Angioedema after the first dose of Covishield (adenovirus-vectored severe acute respiratory syndrome coronavirus 2 vaccine): follow-up after the second and third booster doses.Revista da Sociedade Brasileira de Medicina Tropical2022name in title: Covishield
PMID 35617826Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: The pragmatic, multi-center, three-arm, partially randomized HEVACC trial.EBioMedicine2022cited by trial NCT04907331
PMID 35620997Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin2022name in abstract: Vaxzevria
PMID 35638589Immunogenicity of the mRNA-1273 and ChAdOx1 nCoV-19 vaccines in Asian patients with autoimmune rheumatic diseases under biologic and/or conventional immunosuppressant treatments.Scandinavian journal of rheumatology2022name in title: ChAdOx1 nCoV-19
PMID 35642187Alopecia universalis with unusual histopathologic features after vaccination with ChAdOx1 nCoV-19 (AZD1222).JAAD case reports2022name in title: ChAdOx1 nCoV-19
PMID 35644585[Thrombosis with Thrombocytopenia Syndrome after ChAdOx1 nCoV-19 vaccination].Rinsho shinkeigaku = Clinical neurology2022name in title: ChAdOx1 nCoV-19
PMID 35646371Guillain-Barré syndrome following coronavirus disease vaccine: First report from Nepal.SAGE open medical case reports2022name in abstract: ChAdOx1 nCoV-19
PMID 35648014Retinal venous occlusion following COVID-19 vaccination: Report of a case after third dose and review of the literature.Indian journal of ophthalmology2022name in abstract: Covishield
PMID 35649718Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.Clinical journal of the American Society of Nephrology : CJASN2022name in abstract: AZD1222
PMID 35653651COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion.Ocular immunology and inflammation2022name in abstract: ChAdOx1 nCoV-19
PMID 35656609[Newly diagnosed melanoma diagnosed on the basis of cutaneous side effects from COVID-19 vaccine].Ugeskrift for laeger2022name in abstract: Vaxzevria
PMID 35660284Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19.Medicina intensiva2022name in title: ChAdOx1 nCoV-19
PMID 35678536Sarcoidosis presenting as bilateral optic neuritis after ChAdOx1 nCoV-19 vaccination.Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace2022name in title: ChAdOx1 nCoV-19
PMID 35685574Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.International journal of clinical practice2022name in title: AZD1222
PMID 35690076Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial.The Lancet. Respiratory medicine2022name in abstract: ChAdOx1 nCoV-19
PMID 35691324Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.Lancet (London, England)2022name in title: ChAdOx1 nCoV-19
PMID 35692333Generalized Edema and Pseudothrombocytopenia After ChAdOx1 nCoV-19 COVID-19 Vaccination: A Case Report.Frontiers in public health2022name in title: ChAdOx1 nCoV-19
PMID 35692661Extensive Longitudinal Transverse Myelitis Temporally Related to the Use of AZD1222, AstraZeneca COVID-19 Vaccine: Cerebrospinal Fluid Analysis and Recent Data Review.Case reports in neurological medicine2022name in title: AZD1222
PMID 35728642Immunogenicity of a single dose of BNT162b2, ChAdOx1 nCoV-19, or CoronaVac against SARS-CoV-2 delta and omicron variants among previously infected adults: A randomized trial.The Journal of infection2022name in title: ChAdOx1 nCoV-19
PMID 35737110MOG encephalomyelitis after vaccination against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2): case report and comprehensive review of the literature.Journal of neurology2022name in abstract: ChAdOx1 nCoV-19
PMID 35746538Non-Arteritic Anterior Ischemic Optic Neuropathy Following COVID-19 Vaccination.Vaccines2022name in abstract: ChAdOx1 nCoV-19
PMID 35748853Decreased Antibody Response After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Patients With Down Syndrome.The Journal of infectious diseases2022cited by trial NCT05145348
PMID 35749755Matched Versus Mixed COVID-19 Vaccinations in Korean Solid Organ Transplant Recipients: An Observational Study.Transplantation2022name in abstract: ChAdOx1 nCoV-19
PMID 35751472Associations of Guillain-Barré syndrome with coronavirus disease 2019 vaccination: Disproportionality analysis using the World Health Organization pharmacovigilance database.Journal of the peripheral nervous system : JPNS2022name in abstract: ChAdOx1 nCoV-19
PMID 35754076Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study.Internal and emergency medicine2022name in abstract: Vaxzevria
PMID 35760939An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.Clinical rheumatology2022name in abstract: ChAdOx1 nCoV-19
PMID 35773944Covid-19 vaccination in autoimmune rheumatic diseases: A multi-center survey from southern India.International journal of rheumatic diseases2022name in abstract: ChAdOx1 nCoV-19
PMID 35774673Polymyalgia Rheumatica After ChAdOx1 nCov-19 Vaccine: A Case Report.Cureus2022name in title: ChAdOx1 nCoV-19
PMID 35774715A Case of Giant Cell Arteritis With a Normal Erythrocyte Sedimentation Rate (ESR) Post ChAdOx1 nCoV-19 Vaccination.Cureus2022name in title: ChAdOx1 nCoV-19
PMID 35781813The short term safety of COVID-19 vaccines in Australia: AusVaxSafety active surveillance, February - August 2021.The Medical journal of Australia2022name in abstract: Vaxzevria
PMID 35792752Reactogenicity, immunogenicity, and humoral immune response dynamics after the third dose of heterologous COVID-19 vaccines in participants fully vaccinated with inactivated vaccine.Expert review of vaccines2022name in abstract: AZD1222
PMID 35795713Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.EClinicalMedicine2022cited by trial NCT05378191
PMID 35799872Subacute thyroiditis after receiving the vaccine for COVID-19: a case report and literature review.Clinical and experimental vaccine research2022name in abstract: ChAdOx1 nCoV-19
PMID 35799877Thalamic hemi-chorea: a rare complication after receiving the adenoviral vector-based COVID-19 vaccine: a case report.Clinical and experimental vaccine research2022name in abstract: ChAdOx1 nCoV-19
PMID 35800401Myasthenia gravis with ocular symptoms following a ChAdOx1 nCoV-19 vaccination: A case report.American journal of ophthalmology case reports2022name in title: ChAdOx1 nCoV-19
PMID 35800512Vaccine-induced thrombosis and thrombocytopenia (VITT); Exploring the unknown.Journal of family medicine and primary care2022name in abstract: ChAdOx1 nCoV-19
PMID 35800833Acute Myocardial Infarction After COVID-19 Vaccination: A Case Report.Cureus2022name in abstract: ChAdOx1 nCoV-19
PMID 35816053Immunogenicity and reactogenicity against the SARS-CoV-2 variants following heterologous primary series involving CoronaVac, ChAdox1 nCov-19 and BNT162b2 plus BNT162b2 booster vaccination: An open-label randomized study in healthy Thai adults.Human vaccines & immunotherapeutics2022name in title: ChAdOx1 nCoV-19
PMID 35818570Unilateral recurrent central serous chorioretinopathy (CSCR) following COVID-19 vaccination- A multimodal imaging study.American journal of ophthalmology case reports2022name in abstract: Covishield
PMID 35818815Symptomatic hyponatremia after ChAdOx1 nCoV-19 coronavirus disease-19 vaccination.Clinical nephrology2022name in title: ChAdOx1 nCoV-19
PMID 35821156Transjugular intrahepatic portosystemic shunt, local thrombaspiration, and lysis for management of fulminant portomesenteric thrombosis and atraumatic splenic rupture due to vector-vaccine-induced thrombotic thrombocytopenia: a case report.Journal of medical case reports2022name in abstract: ChAdOx1 nCoV-19
PMID 35832754Central Retinal Vein Occlusion Following the First Dose of COVID Vaccine.Cureus2022name in abstract: Covishield
PMID 35850789Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine.BMJ case reports2022name in title: ChAdOx1 nCoV-19
PMID 35877063Acute vestibular neuritis: A rare complication after the adenoviral vector-based COVID-19 vaccine.Journal of neurovirology2022name in abstract: ChAdOx1 nCoV-19
PMID 35940202Determinants of COVID-19 Breakthrough Infections and Severity in ChAdOx1 nCoV-19-Vaccinated Priority Groups.The American journal of tropical medicine and hygiene2022name in title: ChAdOx1 nCoV-19
PMID 35940668A 54-Year-Old Man With Migratory Pulmonary Consolidation and Progressive Dyspnea.Chest2022name in abstract: ChAdOx1 nCoV-19
PMID 35966159Delayed urticaria after BNT162b2 booster vaccination at previous intradermal test site with severe acute respiratory syndrome-coronavirus-2 spike protein.Asia Pacific allergy2022name in abstract: ChAdOx1 nCoV-19
PMID 35967524Post Covishield (ChAdOx1 nCoV-19) Vaccination: New Onset Focal Segmental Glomerulosclerosis Resistant to Steroid and Calcineurin Inhibitor.Indian journal of nephrology2022name in title: ChAdOx1 nCoV-19
PMID 35975341Longitudinally extensive transverse myelitis following ChAdOx1 nCoV-19 vaccine.Journal of postgraduate medicine2022name in title: ChAdOx1 nCoV-19
PMID 35976470Anaphylaxis to SARS-CoV-2 Vaccines in the Setting of a Nationwide Passive Epidemiological Surveillance Program.Journal of clinical immunology2022name in abstract: ChAdOx1 nCoV-19
PMID 35989780Myelin Oligodendrocyte Glycoprotein Antibody Disease After COVID-19 Vaccination - Causal or Incidental?Cureus2022name in abstract: ChAdOx1 nCoV-19
PMID 35999428Active Safety Surveillance of Four Types of COVID-19 Vaccines: A National Study from Jordan.Clinical drug investigation2022name in abstract: ChAdOx1 nCoV-19
PMID 36016107Lymphedema of the Arm after COVID-19 Vaccination in a Patient with Hidden Breast Cancer and Paraneoplastic Dermatomyositis.Vaccines2022name in abstract: Vaxzevria
PMID 36016174Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination.Vaccines2022name in title: ChAdOx1 nCoV-19
PMID 36053935Postvaccinal GABA-B receptor antibody encephalitis after ChAdOx1 nCoV-19 vaccination.Annals of clinical and translational neurology2022name in title: ChAdOx1 nCoV-19
PMID 36054163Transverse Myelitis Following SARS-CoV-2 Vaccination: A Pharmacoepidemiological Study in the World Health Organization's Database.Annals of neurology2022name in abstract: ChAdOx1 nCoV-19
PMID 36075233Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial.The Lancet. Infectious diseases2022cited by trial NCT04864561
PMID 36097029Heterologous vector versus homologous mRNA COVID-19 booster vaccination in non-seroconverted immunosuppressed patients: a randomized controlled trial.Nature communications2022name in abstract: ChAdOx1 nCoV-19
PMID 36105772Atypical acute disseminated encephalomyelitis with systemic inflammation after a first dose of AztraZaneca COVID-19 vaccine. A case report.Frontiers in neurology2022name in abstract: ChAdOx1 nCoV-19
PMID 36105814Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project.Frontiers in immunology2022name in title: ChAdOx1 nCoV-19
PMID 36106642Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months.The Journal of clinical investigation2022cited by trial NCT04516746
PMID 36110335COVID-19 vaccine-associated myositis - a case report.Clinical case reports2022name in abstract: ChAdOx1 nCoV-19
PMID 36115850A randomized controlled trial of heterologous ChAdOx1 nCoV-19 and recombinant subunit vaccine MVC-COV1901 against COVID-19.Nature communications2022name in title: ChAdOx1 nCoV-19
PMID 36120199Parsonage-Turner Syndrome Following Covishield (AstraZeneca ChAdOx1 nCoV-19) Vaccination: A Case Report.Cureus2022name in title: ChAdOx1 nCoV-19
PMID 36145196Vitamin D Supplementation Does Not Influence SARS-CoV-2 Vaccine Efficacy or Immunogenicity: Sub-Studies Nested within the CORONAVIT Randomised Controlled Trial.Nutrients2022name in abstract: ChAdOx1 nCoV-19
PMID 36146992A probable case of vaccine-induced immune thrombotic thrombocytopenia secondary to Pfizer Comirnaty COVID-19 vaccine.The journal of the Royal College of Physicians of Edinburgh2022name in abstract: ChAdOx1 nCoV-19
PMID 36159410Rapid progressive vaccine-induced immune thrombotic thrombocytopenia with cerebral venous thrombosis after ChAdOx1 nCoV-19 (AZD1222) vaccination: A case report.World journal of clinical cases2022name in title: ChAdOx1 nCoV-19
PMID 36169102COVID-19 Vaccination in Solid-Organ Transplant: A Real-World Multicenter Experience.Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation2022name in abstract: Covishield
PMID 36176309Acquired hemophilia following COVID-19 vaccination: Case report and review of literature.Research and practice in thrombosis and haemostasis2022name in abstract: Vaxzevria
PMID 36177263Bilateral adrenal haemorrhage with renal infarction after ChAdOx1 nCoV-19 AstraZeneca vaccination.BJR case reports2022name in title: ChAdOx1 nCoV-19
PMID 36180032Effect of Inactivated SARS-CoV-2 Vaccines and ChAdOx1 nCoV-19 Vaccination to Prevent COVID-19 in Thai Households (VacPrevent trial).International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2022name in title: ChAdOx1 nCoV-19
PMID 36183151Lichen planus pigmentosus post COVID-19-vaccination: A case report with literature review.Dermatologic therapy2022name in abstract: ChAdOx1 nCoV-19
PMID 36185940COVID-19 Vaccine-Induced Thrombotic Thrombocytopaenia With Venous and Arterial Thrombosis: A Case Report.Cureus2022name in abstract: AZD1222
PMID 36190083A rare case of cortical blindness following vaccination against SARS-CoV-2.Indian journal of ophthalmology2022name in abstract: Covishield
PMID 36202639Immune response after COVID-19 vaccination among patients with chronic kidney disease and kidney transplant.Vaccine2022name in abstract: ChAdOx1 nCoV-19
PMID 36205996Association Between Vaccination Status and Mortality Among Intubated Patients With COVID-19-Related Acute Respiratory Distress Syndrome.JAMA network open2022name in abstract: ChAdOx1 nCoV-19
PMID 36211366Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital.Frontiers in immunology2022name in abstract: Covishield
PMID 36229342Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial.EBioMedicine2022name in abstract: ChAdOx1 nCoV-19
PMID 36247451Case report: Sudden cardiorespiratory collapse in a healthy male after coronavirus disease 2019 vaccination at a vaccination center.Frontiers in cardiovascular medicine2022name in abstract: ChAdOx1 nCoV-19
PMID 36267879Case report: Vaccine-induced immune thrombotic thrombocytopenia complicated by acute cerebral venous thrombosis and hemorrhage after AstraZeneca vaccines followed by Moderna COVID-19 vaccine booster and surgery.Frontiers in neurology2022name in abstract: ChAdOx1 nCoV-19
PMID 36274082COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study.Clinical drug investigation2022name in abstract: Vaxzevria
PMID 36298516A Case Report: Multifocal Necrotizing Encephalitis and Myocarditis after BNT162b2 mRNA Vaccination against COVID-19.Vaccines2022name in abstract: ChAdOx1 nCoV-19
PMID 36298523Temporal Association between Hampton's Hump Pulmonary Embolism and First-Dose ChAdOx1 nCov-19 Vaccine in a Patient with Activated Protein C Resistance.Vaccines2022name in title: ChAdOx1 nCoV-19
PMID 36309347The Incidence and Effect of Adverse Events Due to COVID-19 Vaccines on Breakthrough Infections: Decentralized Observational Study With Underrepresented Groups.JMIR formative research2022cited by trial NCT04832932
PMID 36348600Safety, immunogenicity & effectiveness of the COVID-19 vaccine among healthcare workers in a tertiary care hospital.The Indian journal of medical research2022name in abstract: ChAdOx1 nCoV-19
PMID 36352970Role of vaccination in COVID-19.Journal of family medicine and primary care2022name in abstract: Covishield
PMID 36357291Guillain-Barré syndrome temporally associated with COVID-19 vaccines in Victoria, Australia.Vaccine2022name in abstract: Vaxzevria
PMID 36357712Immune correlates analysis of the ENSEMBLE single Ad26.COV2.S dose vaccine efficacy clinical trial.Nature microbiology2022name in abstract: AZD1222
PMID 36366396Bilateral Optic Neuritis after COVID-19 Vaccination: A Case Report.Vaccines2022name in abstract: ChAdOx1 nCoV-19
PMID 36399969Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, randomized clinical trial.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology2022name in title: ChAdOx1 nCoV-19
PMID 36405586Case report: Early onset Marin-Amat syndrome after receiving ChAdOx1 nCoV-19 vaccination.Frontiers in medicine2022name in title: ChAdOx1 nCoV-19
PMID 36426114Adult-onset Still's disease after ChAdOx1 nCoV-19 vaccine: a possible association.Autopsy & case reports2022name in title: ChAdOx1 nCoV-19
PMID 36449641Guillain-Barré syndrome after COVID-19 vaccination: report of two cases from Vietnam.Journal of infection in developing countries2022name in abstract: ChAdOx1 nCoV-19
PMID 36451671Livedo reticularis following administration of ChAdOx1 nCoV-19 vaccine (AZD1222): a report of two cases.Clinical and experimental vaccine research2022name in title: ChAdOx1 nCoV-19
PMID 36451672Deep vein thrombosis and acute hepatitis after ChAdOx1 nCov-19 vaccination in a Charcot-Marie-Tooth patient: a case report.Clinical and experimental vaccine research2022name in title: ChAdOx1 nCoV-19
PMID 36465571Anti-GBM Disease after Oxford-AstraZeneca ChAdOx1 nCoV-19 Vaccination: A Report of Two Cases.Case reports in nephrology and dialysis2022name in title: ChAdOx1 nCoV-19
PMID 36476088Bilateral Carpal Tunnel Syndrome Following COVID-19 Vaccination: A Case Report.The journal of hand surgery Asian-Pacific volume2022name in abstract: ChAdOx1 nCoV-19
PMID 36544589Guillain-Barré Syndrome and Unilateral Optic Neuritis Following Vaccination for COVID-19: A Case Report and Literature Review.Neuro-ophthalmology (Aeolus Press)2022name in abstract: Vaxzevria
PMID 36560466Resistance towards ChadOx1 nCoV-19 in an 83 Years Old Woman Experiencing Vaccine Induced Thrombosis with Thrombocytopenia Syndrome.Vaccines2022name in title: ChAdOx1 nCoV-19
PMID 36560660Determinants of Anti-S Immune Response at 9 Months after COVID-19 Vaccination in a Multicentric European Cohort of Healthcare Workers-ORCHESTRA Project.Viruses2022name in abstract: Vaxzevria
PMID 36618145Minimal change disease (MCD) following vaccination with ChAdOx1 nCoV-19 vaccine in a young Indian male: A case report.Journal of family medicine and primary care2022name in title: ChAdOx1 nCoV-19
PMID 36618216A case of ischemic stroke and transient thrombocytopenia in a young female following adenoviral vector-based COVID-19 vaccination: Was the association incidental or causal?Journal of family medicine and primary care2022name in abstract: ChAdOx1 nCoV-19
PMID 36618419The safety of COVID-19 vaccines in patients with myasthenia gravis: A scoping review.Frontiers in immunology2022name in abstract: ChAdOx1 nCoV-19
PMID 36655834[Possible vaccine-induced immune thrombotic thrombocytopenia in a patient with diabetes and chronic kidney disease or random association?].Giornale italiano di nefrologia : organo ufficiale della Societa italiana di nefrologia2022name in abstract: ChAdOx1 nCoV-19
PMID 36713413Robust humoral and cellular recall responses to AZD1222 attenuate breakthrough SARS-CoV-2 infection compared to unvaccinated.Frontiers in immunology2022cited by trial NCT04516746
PMID 38620988COVID-19 vaccine (Ad26.COV2.S), an unlikely culprit of portal vein thrombosis in a middle-aged man.Thrombosis update2022name in abstract: ChAdOx1 nCoV-19
PMID 40477992Mechanical prosthetic valve thrombosis after ChAdOx1-nCoV-19 vaccination: A case report.IHJ cardiovascular case reports2022name in title: ChAdOx1 nCoV-19
PMID 33220855Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.Lancet (London, England)2021cited by trial NCT04400838
PMID 33306989Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.Lancet (London, England)2021cited by trial NCT04324606
PMID 33335322Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses.Nature medicine2021cited by trial NCT04324606
PMID 33335323T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial.Nature medicine2021cited by trial NCT04400838
PMID 33617777Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.Lancet (London, England)2021cited by trial NCT04324606
PMID 33725432Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant.The New England journal of medicine2021cited by trial NCT04444674
PMID 33798499Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.Lancet (London, England)2021cited by trial NCT04400838
PMID 33835768Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.The New England journal of medicine2021name in title: ChAdOx1 nCoV-19
PMID 33835769Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.The New England journal of medicine2021name in title: ChAdOx1 nCoV-19
PMID 33864750Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination.Lancet (London, England)2021name in title: ChAdOx1 nCoV-19
PMID 33877735Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT).Journal of thrombosis and haemostasis : JTH2021name in abstract: ChAdOx1 nCoV-19
PMID 33877737Thrombocytopenia with acute ischemic stroke and bleeding in a patient newly vaccinated with an adenoviral vector-based COVID-19 vaccine.Journal of thrombosis and haemostasis : JTH2021name in abstract: AZD1222
PMID 33901420Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.Lancet (London, England)2021name in abstract: ChAdOx1 nCoV-19
PMID 33901423COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.Lancet (London, England)2021name in abstract: ChAdOx1 nCoV-19
PMID 33909350An observational study to identify the prevalence of thrombocytopenia and anti-PF4/polyanion antibodies in Norwegian health care workers after COVID-19 vaccination.Journal of thrombosis and haemostasis : JTH2021name in abstract: AZD1222
PMID 33929487US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.JAMA2021name in abstract: ChAdOx1 nCoV-19
PMID 33930320Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study.The Lancet. Infectious diseases2021name in abstract: ChAdOx1 nCoV-19
PMID 33945605A flow cytometric assay to detect platelet-activating antibodies in VITT after ChAdOx1 nCov-19 vaccination.Blood2021name in title: ChAdOx1 nCoV-19
PMID 33981305Acute Transverse Myelitis (ATM):Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222).Frontiers in immunology2021name in title: ChAdOx1 nCoV-19
PMID 34035134Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.Journal of neurology, neurosurgery, and psychiatry2021name in title: ChAdOx1 nCoV-19
PMID 34036570AZD1222 vaccine-related coagulopathy and thrombocytopenia without thrombosis in a young female.British journal of haematology2021name in title: AZD1222
PMID 34049307Using Nonheparin Anticoagulant to Treat a Near-Fatal Case With Multiple Venous Thrombotic Lesions During ChAdOx1 nCoV-19 Vaccination-Related Vaccine-Induced Immune Thrombotic Thrombocytopenia.Critical care medicine2021name in title: ChAdOx1 nCoV-19
PMID 34050904Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study.Journal of nephrology2021name in abstract: ChAdOx1 nCoV-19
PMID 34107198Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia.The New England journal of medicine2021name in abstract: ChAdOx1 nCoV-19
PMID 34111682Successful treatment of acute spleno-porto-mesenteric vein thrombosis after ChAdOx1 nCoV-19 vaccine. A case report.Journal of critical care2021name in title: ChAdOx1 nCoV-19
PMID 34115963Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination.The lancet. Gastroenterology & hepatology2021name in title: ChAdOx1 nCoV-19
PMID 34135077ChAdOx1 nCOV-19 vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis (CVST).BMJ case reports2021name in title: ChAdOx1 nCoV-19
PMID 34137813A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2.Blood advances2021name in title: ChAdOx1 nCoV-19
PMID 34153264Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial.The lancet. HIV2021cited by trial NCT04400838
PMID 34153802New-onset refractory status epilepticus following the ChAdOx1 nCoV-19 vaccine.Journal of neuroimmunology2021name in title: ChAdOx1 nCoV-19
PMID 34159588Vaccine-induced immune thrombotic thrombocytopenia (VITT) - a novel clinico-pathological entity with heterogeneous clinical presentations.British journal of haematology2021name in abstract: ChAdOx1 nCoV-19
PMID 34169493PF4-Dependent Immunoassays in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: Results of an Interlaboratory Comparison.Thrombosis and haemostasis2021name in abstract: ChAdOx1 nCoV-19
PMID 34171649Vaccine-Induced Immune Thrombotic Thrombocytopenia with Disseminated Intravascular Coagulation and Death following the ChAdOx1 nCoV-19 Vaccine.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2021name in title: ChAdOx1 nCoV-19
PMID 34172647Successful Liver Transplantation From a Deceased Donor With Vaccine-Induced Thrombotic Thrombocytopenia Causing Cerebral Venous Sinus and Hepatic Veins Thrombosis After ChAdOx1 nCov-19 Vaccination.Transplantation2021name in title: ChAdOx1 nCoV-19
PMID 34175640Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2021name in title: ChAdOx1 nCoV-19
PMID 34181880Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.Lancet (London, England)2021cited by trial NCT05378191
PMID 34182207A case of longitudinally extensive transverse myelitis following vaccination against Covid-19.Journal of neuroimmunology2021name in abstract: AZD1222
PMID 34187278Acute Macular Neuroretinopathy following Coronavirus Disease 2019 Vaccination.Ocular immunology and inflammation2021name in abstract: Vaxzevria
PMID 34205940DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination.Viruses2021name in title: ChAdOx1 nCoV-19
PMID 34214206AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report.Journal of medical virology2021name in title: AZD1222
PMID 34225251Auto-immune hepatitis following COVID vaccination.Journal of autoimmunity2021name in abstract: Covishield
PMID 34242687Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.American journal of kidney diseases : the official journal of the National Kidney Foundation2021name in abstract: ChAdOx1 nCoV-19
PMID 34244448Cerebral venous sinus thrombosis after ChAdOx1 nCov-19 vaccination with a misleading first cerebral MRI scan.Stroke and vascular neurology2021name in title: ChAdOx1 nCoV-19
PMID 34256983Primary adrenal insufficiency associated with Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia (VITT).European journal of internal medicine2021name in title: ChAdOx1 nCoV-19
PMID 34257129Thrombosis and thrombocytopaenia after ChAdOx1 nCoV-19 vaccination: a single UK centre experience.BMJ case reports2021name in title: ChAdOx1 nCoV-19
PMID 34265462Effectiveness of mRNA-BNT162b2, mRNA-1273, and ChAdOx1 nCoV-19 vaccines against COVID-19 in healthcare workers: an observational study using surveillance data.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2021name in title: ChAdOx1 nCoV-19
PMID 34272622A case of acute demyelinating polyradiculoneuropathy with bilateral facial palsy after ChAdOx1 nCoV-19 vaccine.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology2021name in title: ChAdOx1 nCoV-19
PMID 34273119Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: A case report.Acta neurologica Scandinavica2021name in title: ChAdOx1 nCoV-19
PMID 34297792Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19).Blood2021name in title: ChAdOx1 nCoV-19
PMID 34312554Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19/mRNA vaccination.Nature medicine2021name in title: ChAdOx1 nCoV-19
PMID 34323939Prothrombotic immune thrombocytopenia after COVID-19 vaccination.Blood2021name in abstract: Vaxzevria
PMID 34324214Postvaccinal Encephalitis after ChAdOx1 nCov-19.Annals of neurology2021name in title: ChAdOx1 nCoV-19
PMID 34330729Guillain-Barré syndrome after COVID-19 vaccination.BMJ case reports2021name in abstract: Vaxzevria
PMID 34341335The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment.Blood cancer journal2021name in abstract: AZD1222
PMID 34341358Malignant cerebral infarction after ChAdOx1 nCov-19 vaccination: a catastrophic variant of vaccine-induced immune thrombotic thrombocytopenia.Nature communications2021name in title: ChAdOx1 nCoV-19
PMID 34350668Onset/flare of psoriasis following the ChAdOx1 nCoV-19 Corona virus vaccine (Oxford-AstraZeneca/Covishield): Report of two cases.Dermatologic therapy2021name in title: ChAdOx1 nCoV-19
PMID 34355379Vaccine-induced severe thrombotic thrombocytopenia following COVID-19 vaccination: a report of an autoptic case and review of the literature.European review for medical and pharmacological sciences2021name in abstract: ChAdOx1 nCoV-19
PMID 34360156COVID-19 Vaccines Safety Tracking (CoVaST): Protocol of a Multi-Center Prospective Cohort Study for Active Surveillance of COVID-19 Vaccines' Side Effects.International journal of environmental research and public health2021cited by trial NCT04834869
PMID 34362727Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2021name in title: ChAdOx1 nCoV-19
PMID 34363717Herpes zoster after ChAdOx1 nCoV-19 vaccine: a case series.Journal of the European Academy of Dermatology and Venereology : JEADV2021name in title: ChAdOx1 nCoV-19
PMID 34370971Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.Lancet (London, England)2021name in abstract: ChAdOx1 nCoV-19
PMID 34375510Comparison of adverse drug reactions among four COVID-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites.Journal of thrombosis and haemostasis : JTH2021name in abstract: ChAdOx1 nCoV-19
PMID 34377889Secondary Immune Thrombocytopenia (ITP) Associated with ChAdOx1 Covid-19 Vaccination - A Case Report.TH open : companion journal to thrombosis and haemostasis2021name in abstract: ChAdOx1 nCoV-19
PMID 34384129Venous Thromboembolism and Mild Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.Thrombosis and haemostasis2021name in title: ChAdOx1 nCoV-19
PMID 34391547Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study.The Lancet. Respiratory medicine2021name in title: ChAdOx1 nCoV-19
PMID 34392078Acute myelitis and ChAdOx1 nCoV-19 vaccine: Casual or causal association?Journal of neuroimmunology2021name in title: ChAdOx1 nCoV-19
PMID 34393988Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series.Frontiers in neurology2021name in abstract: ChAdOx1 nCoV-19
PMID 34402235Intracerebral Hemorrhage due to Thrombosis with Thrombocytopenia Syndrome after Vaccination against COVID-19: the First Fatal Case in Korea.Journal of Korean medical science2021name in abstract: ChAdOx1 nCoV-19
PMID 34414110Interference of COVID-19 Vaccination With PET/CT Leads to Unnecessary Additional Imaging in a Patient With Metastatic Cutaneous Melanoma-Case Report.Frontiers in oncology2021name in abstract: AZD1222
PMID 34416184A case of ANCA-associated vasculitis after AZD1222 (Oxford-AstraZeneca) SARS-CoV-2 vaccination: casualty or causality?Kidney international2021name in title: AZD1222
PMID 34416193Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial.The lancet. HIV2021cited by trial NCT04444674
PMID 34416410Sensory Guillain-Barre syndrome following the ChAdOx1 nCov-19 vaccine: Report of two cases and review of literature.Journal of neuroimmunology2021name in title: ChAdOx1 nCoV-19
PMID 34420983An old entity, a new trigger: Post COVID-19 vaccine pityriasis rubra pilaris.The International journal of risk & safety in medicine2021name in abstract: Covishield
PMID 34430954Profile of humoral and cellular immune responses to single doses of BNT162b2 or ChAdOx1 nCoV-19 vaccines in residents and staff within residential care homes (VIVALDI): an observational study.The lancet. Healthy longevity2021name in title: ChAdOx1 nCoV-19
PMID 34452028A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization.Vaccines2021name in abstract: ChAdOx1 nCoV-19
PMID 34461442Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2021name in title: ChAdOx1 nCoV-19
PMID 34466769Vaccine-induced immune thrombotic thrombocytopenia following AstraZeneca (ChAdOx1 nCOV19) vaccine-A case report.Research and practice in thrombosis and haemostasis2021name in title: ChAdOx1 nCoV-19
PMID 34477089[Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19].Ugeskrift for laeger2021name in title: ChAdOx1 nCoV-19
PMID 34478433Central Venous Sinus Thrombosis with Subarachnoid Hemorrhage Following an mRNA COVID-19 Vaccination: Are These Reports Merely Co-Incidental?The American journal of case reports2021name in abstract: ChAdOx1 nCoV-19
PMID 34480858Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).Lancet (London, England)2021cited by trial NCT04324606
PMID 34483273Bilateral Immune-Mediated Keratolysis After Immunization With SARS-CoV-2 Recombinant Viral Vector Vaccine.Cornea2021name in abstract: ChAdOx1 nCoV-19
PMID 34485807Deterioration of vaccine-induced immune thrombotic thrombocytopenia treated by heparin and platelet transfusion: Insight from functional cytometry and serotonin release assay.Research and practice in thrombosis and haemostasis2021name in abstract: ChAdOx1 nCoV-19
PMID 34504856Case Report: Two Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccination.Frontiers in medicine2021name in abstract: Vaxzevria
PMID 34508485Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report.JNMA; journal of the Nepal Medical Association2021name in title: Covishield
PMID 34513173A rare case of vaccine-induced immune thrombosis and thrombocytopenia and approach to management.Surgical neurology international2021name in abstract: Covishield
PMID 34527211Safety Warning for ChAdOx1 nCov-19 Vaccine in Patients with Sickle Cell Disease.Mediterranean journal of hematology and infectious diseases2021name in title: ChAdOx1 nCoV-19
PMID 34529762Poor neutralizing antibody responses in 106 patients with WM after vaccination against SARS-CoV-2: a prospective study.Blood advances2021name in abstract: AZD1222
PMID 34548920Guillain-Barré syndrome following ChAdOx1 nCoV-19 COVID-19 vaccination: A case series.Neurology and clinical neuroscience2021name in title: ChAdOx1 nCoV-19
PMID 34556531Rare case of COVID-19 vaccine-associated intracranial haemorrhage with venous sinus thrombosis.BMJ case reports2021name in abstract: ChAdOx1 nCoV-19
PMID 34557507Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination.Frontiers in medicine2021name in abstract: ChAdOx1 nCoV-19
PMID 34571652Bilateral paracentral acute middle maculopathy and acute macular neuroretinopathy following COVID-19 vaccination.Indian journal of ophthalmology2021name in abstract: Covishield
PMID 34580132Acute ST-segment elevation myocardial infarction secondary to vaccine-induced immune thrombosis with thrombocytopaenia (VITT).BMJ case reports2021name in abstract: ChAdOx1 nCoV-19
PMID 34581763Characteristics and Outcomes of Patients With Cerebral Venous Sinus Thrombosis in SARS-CoV-2 Vaccine-Induced Immune Thrombotic Thrombocytopenia.JAMA neurology2021name in abstract: ChAdOx1 nCoV-19
PMID 34587382Phase 3 Safety and Efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 Vaccine.The New England journal of medicine2021cited by trial NCT04516746
PMID 34590397Sweet syndrome after Oxford-AstraZeneca COVID-19 vaccine (AZD1222) in an elderly female.Dermatologic therapy2021name in title: AZD1222
PMID 34592707Consumption of complement in a 26-year-old woman with severe thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination.Journal of autoimmunity2021name in title: ChAdOx1 nCoV-19
PMID 34594203Darier's Disease Flare following COVID-19 Vaccine.Case reports in dermatology2021name in abstract: Vaxzevria
PMID 34607818Acute-onset chronic inflammatory demyelinating polyneuropathy after COVID-19 infection and subsequent ChAdOx1 nCoV-19 vaccination.BMJ case reports2021name in title: ChAdOx1 nCoV-19
PMID 34613799Comparison of the Results of Five SARS-CoV-2 Antibody Assays before and after the First and Second ChAdOx1 nCoV-19 Vaccinations among Health Care Workers: a Prospective Multicenter Study.Journal of clinical microbiology2021name in title: ChAdOx1 nCoV-19
PMID 34615534Diffuse prothrombotic syndrome after ChAdOx1 nCoV-19 vaccine administration: a case report.Journal of medical case reports2021name in title: ChAdOx1 nCoV-19
PMID 34615860Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 lineages circulating in Brazil.Nature communications2021name in title: ChAdOx1 nCoV-19
PMID 34620638Haematuria, a widespread petechial rash, and headaches following the Oxford AstraZeneca ChAdOx1 nCoV-19 Vaccination.BMJ case reports2021name in title: ChAdOx1 nCoV-19
PMID 34622311Adverse events of six COVID-19 vaccines in patients with autoimmune rheumatic diseases: a cross-sectional study.Rheumatology international2021name in abstract: ChAdOx1 nCoV-19
PMID 34625443Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine.BMJ case reports2021name in title: ChAdOx1 nCoV-19
PMID 34625447Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination.BMJ case reports2021name in title: ChAdOx1 nCoV-19
PMID 34641797Longitudinal extensive transverse myelitis following ChAdOx1 nCOV-19 vaccine: a case report.BMC neurology2021name in title: ChAdOx1 nCoV-19
PMID 34650896Myocardial Infarction and Azygos Vein Thrombosis After ChAdOx1 nCoV-19 Vaccination in a Hemodialysis Patient.Cureus2021name in title: ChAdOx1 nCoV-19
PMID 34668675Covishield India: demystifying myths through an early multicenter study.The American journal of managed care2021name in title: Covishield
PMID 34679140Thrombotic thrombocytopenia following ChAdOx1 nCov-19 vaccination.Acute medicine2021name in title: ChAdOx1 nCoV-19
PMID 34684047Acute Transverse Myelitis after COVID-19 Vaccination.Medicina (Kaunas, Lithuania)2021name in abstract: ChAdOx1 nCoV-19
PMID 34696186Henoch-Schönlein Purpura Following the First Dose of COVID-19 Viral Vector Vaccine: A Case Report.Vaccines2021name in abstract: ChAdOx1 nCoV-19
PMID 34696248Humoral Response Induced by Prime-Boost Vaccination with the ChAdOx1 nCoV-19 and mRNA BNT162b2 Vaccines in a Teriflunomide-Treated Multiple Sclerosis Patient.Vaccines2021name in title: ChAdOx1 nCoV-19
PMID 34706921Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India.BMJ case reports2021name in abstract: Covishield
PMID 34741583Recurrence of alopecia areata after covid-19 vaccination: A report of three cases in Italy.Journal of cosmetic dermatology2021name in abstract: AZD1222
PMID 34744992Case Report: Multiple Sclerosis Relapses After Vaccination Against SARS-CoV2: A Series of Clinical Cases.Frontiers in neurology2021name in abstract: ChAdOx1 nCoV-19
PMID 34751013A Case Report of Immune Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.Journal of Korean medical science2021name in title: ChAdOx1 nCoV-19
PMID 34786370Utility of skin testing in assessment of post-AZD1222 vaccine (AstraZeneca) allergic reactions: case series in Vietnam.Asia Pacific allergy2021name in title: AZD1222
PMID 34790811An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine-a case report.Annals of translational medicine2021name in abstract: ChAdOx1 nCoV-19
PMID 34804334Serious adverse events following immunization after ChAdOx1 nCov-19 vaccination in India: a single center experience.The Pan African medical journal2021name in title: ChAdOx1 nCoV-19
PMID 34811978Multisystem Inflammatory Syndrome in an Adult after COVID-19 Vaccination: a Case Report and Literature Review.Journal of Korean medical science2021name in abstract: ChAdOx1 nCoV-19
PMID 34812326Acute Eosinophilic Pneumonia Associated With the Anti-COVID-19 Vaccine AZD1222.Cureus2021name in title: AZD1222
PMID 34827040Acute graft rejection in a high-risk corneal transplant following COVID-19 vaccination: A case report.Indian journal of ophthalmology2021name in abstract: ChAdOx1 nCoV-19
PMID 34835151Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly Recipient.Vaccines2021name in title: ChAdOx1 nCoV-19
PMID 34835280Retinal Vascular Events after mRNA and Adenoviral-Vectored COVID-19 Vaccines-A Case Series.Vaccines2021name in abstract: Vaxzevria
PMID 34853744Cutaneous Leukocytoclastic Vasculitis Induction Following ChAdOx1 nCoV-19 Vaccine.Cureus2021name in title: ChAdOx1 nCoV-19
PMID 34862234Lessons of the month 3: Haemophagocytic lymphohistiocytosis following COVID-19 vaccination (ChAdOx1 nCoV-19).Clinical medicine (London, England)2021name in title: ChAdOx1 nCoV-19
PMID 34863358Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.Lancet (London, England)2021name in title: ChAdOx1 nCoV-19
PMID 34876440Post-COVID-19 vaccination occurrence of splenic infarction due to arterial thrombosis.BMJ case reports2021name in abstract: ChAdOx1 nCoV-19
PMID 34880826Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome.Frontiers in neurology2021name in abstract: ChAdOx1 nCoV-19
PMID 34889361Clots in unusual places: lots of stress, limited data, critical decisions.Hematology. American Society of Hematology. Education Program2021name in abstract: ChAdOx1 nCoV-19
PMID 34899739Anti-SARS-CoV-2 Spike Protein RBD Antibody Levels After Receiving a Second Dose of ChAdOx1 nCov-19 (AZD1222) Vaccine in Healthcare Workers: Lack of Association With Age, Sex, Obesity, and Adverse Reactions.Frontiers in immunology2021name in title: ChAdOx1 nCoV-19
PMID 34903200A case report of ChAdOx1 nCoV-19 vaccine-associated encephalitis.BMC neurology2021name in title: ChAdOx1 nCoV-19
PMID 34903275Parsonage-Turner syndrome following coronavirus disease 2019 immunization with ChAdOx1-S vaccine: a case report and review of the literature.Journal of medical case reports2021name in abstract: Vaxzevria
PMID 34926985Autonomic dysfunction post-inoculation with ChAdOx1 nCoV-19 vaccine.European heart journal. Case reports2021name in title: ChAdOx1 nCoV-19
PMID 34950880Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE study.Nature cancer2021name in abstract: AZD1222
PMID 34957365Sudden sensorineural hearing loss after covid-19 vaccine; A possible adverse reaction?Otolaryngology case reports2021name in abstract: Vaxzevria
PMID 34960248Chronic Inflammatory Demyelinating Polyneuropathy after ChAdOx1 nCoV-19 Vaccination.Vaccines2021name in title: ChAdOx1 nCoV-19
PMID 34975092Post coronavirus disease-2019 vaccination Guillain-Barré syndrome.Indian journal of public health2021name in abstract: ChAdOx1 nCoV-19
PMID 35059416Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia.Frontiers in medicine2021name in abstract: ChAdOx1 nCoV-19
PMID 35116025Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2.Frontiers in immunology2021name in title: ChAdOx1 nCoV-19
PMID 35121899Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study.Nature cancer2021name in abstract: AZD1222
PMID 35185757Case Series: Acute Hemorrhagic Encephalomyelitis After SARS-CoV-2 Vaccination.Frontiers in neurology2021name in abstract: ChAdOx1 nCoV-19
PMID 35570336Reactogenicity to ChAdOx1 nCoV-19 vaccine in health care workers: A multicenter observational study in Sri Lanka.The Ceylon medical journal2021name in title: ChAdOx1 nCoV-19
PMID 32702298Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.Lancet (London, England)2020cited by trial NCT04324606

Other papers

Preclinical studies, reviews and other papers that name it, newest 100 shown.

PubMedTitleJournalYearLinked by
PMID 40780270Venous Thrombosis Associated with Different Types of SARS-CoV-2 Vaccines in the Netherlands-Results of the TERA Case-Control Study.Thrombosis and haemostasis2026name in abstract: AZD1222
PMID 41032228Statistical Methods for Multi-jurisdictional Australian Vaccine Safety Investigations of Rare Adverse Events.Drug safety2026name in abstract: Vaxzevria
PMID 41183547Free Nucleic Acids in the ChAdOx1 nCov-19-S Adenovirus Vector Vaccine Contribute to an Anti-platelet Factor 4 Antibody Response.Thrombosis and haemostasis2026name in title: ChAdOx1 nCoV-19
PMID 41187507Discovering metabolic pathways associated with immune activation in people living with HIV following ChAdOx1 nCoV-19 vaccination using mass spectrometry.Journal of pharmaceutical and biomedical analysis2026name in title: ChAdOx1 nCoV-19
PMID 41380832Assessing the association between COVID-19 vaccination and thrombotic thrombocytopenia syndrome (ATTEST Study): Analyses of English data, 2020-2022.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2026name in abstract: AZD1222
PMID 41412017Primary healthcare costs associated with the AstraZeneca COVID-19 vaccine in England.Vaccine2026name in abstract: AZD1222
PMID 41422602Elevated SARS-CoV-2 IgG4 in plasma and mucosa following repeated mRNA boosters impact antibody functions to Omicron and sarbecoviruses.EBioMedicine2026name in abstract: Vaxzevria
PMID 41525819Replication-incompetent viral vaccine vectors ChAdOx1 and MVA as tools for evaluating T-cell responses to naturally processed antigens in vitro.Virus research2026name in abstract: ChAdOx1 nCoV-19
PMID 41547989Association between COVID-19 vaccine efficacy and epidemic force of infection.NPJ vaccines2026name in abstract: AZD1222
PMID 41551849Corrigendum to 'Immunogenicity and safety of Biological E's CORBEVAX™ vaccine as a heterologous booster dose in adult volunteers previously vaccinated with two doses of either COVISHIELD™ or COVAXIN: A Prospective double-blind randomised phase III clinical study' [IJID Regions, volume 17 (2025) 100786].IJID regions2026name in title: Covishield
PMID 41552967Identification of Clinical Factors Associated With the Immunogenicity of Homologous ChAdOx1-nCoV-19 Vaccine in Hemodialysis Patients.The Kaohsiung journal of medical sciences2026name in title: ChAdOx1 nCoV-19
PMID 41608370Effectiveness of COVID-19 Vaccination in Reducing Severity Among SARS-CoV-2 Infected Patients: A Prospective Study From Iraq.Health science reports2026name in abstract: ChAdOx1 nCoV-19
PMID 41708421COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024.Vaccine2026name in abstract: Vaxzevria
PMID 41719246Prediction of COVID-19 hospitalisation, ICU admission or death following ChAdOx1 vaccination using artificial intelligence: A clinical predictive model from the English RAVEN study.PloS one2026name in abstract: AZD1222
PMID 41793342COVID-19 Seroprevalence among Old-age Home Residents of Odisha, India.Indian journal of public health2026name in abstract: Covishield
PMID 41839990Association of COVID-19 vaccines and antibody response in individuals with prior Coronavirus infection.Scientific reports2026name in abstract: Covishield
PMID 41875690Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.Vaccine2026name in title: AZD1222
PMID 41884832Long-term humoral and cellular immune responses following Covaxin vaccination: a 2-year prospective longitudinal study.Frontiers in immunology2026name in abstract: Covishield
PMID 41896708The COVALAC Study: The Impact of COVID-19 Vaccination During Lactation on SARS-CoV-2-Specific Antibodies in Human Milk-A Prospective Cohort Study.Journal of human lactation : official journal of International Lactation Consultant Association2026name in abstract: ChAdOx1 nCoV-19
PMID 41913864Association Between COVID-19 Vaccination, Obesity, and Symptom Burden in a Mexican Population: A Retrospective Cross-Sectional Study.Cureus2026name in abstract: ChAdOx1 nCoV-19
PMID 41920168Prolonged Evaluation of COVID-19 Vaccine Effectiveness in Healthcare Workers at a Public Tertiary Hospital: A Retrospective Cohort Study.Revista da Sociedade Brasileira de Medicina Tropical2026name in abstract: Covishield
PMID 41936925Platelet factor 4 antibody persistence and long-term pathogenicity in vaccine-induced immune thrombotic thrombocytopenia.Journal of thrombosis and haemostasis : JTH2026name in abstract: ChAdOx1 nCoV-19
PMID 41950556Evaluation of vaccine-induced antibody responses against SARS-CoV-2 in multiple myeloma patients from the northeastern region of Mexico.Hematology, transfusion and cell therapy2026name in abstract: AZD1222
PMID 41961244Giant Cell Arteritis Following COVID-19 Vaccination: A Consumer-Stimulated Analysis.Drug safety2026name in abstract: Vaxzevria
PMID 42000737Correlates of severe and delta COVID-19 in a phase 3 trial of the AZD1222 vaccine.NPJ vaccines2026name in title: AZD1222
PMID 42042823Comparison of Immune Responses and Safety Profiles Following a Fourth Heterologous Dose (Second Booster) with mRNA-1273 in Individuals Previously Vaccinated with Two Doses of CoronaVac and a Booster Dose of Either AZD1222 or BNT162b2.Vaccines2026name in title: AZD1222
PMID 42104293The impact of the COVID-19 pandemic on healthy volunteer motivations: a mixed-methods study of participants in plague vaccine trials in the UK and Uganda.BMC public health2026name in abstract: ChAdOx1 nCoV-19
PMID 42150651Lyophilization of a viral vaccine: Strategies for surrogate use in analytical characterization of cake properties and considerations on virus infectivity.Journal of pharmaceutical sciences2026name in abstract: ChAdOx1 nCoV-19
PMID 42155583Batch-dependent safety signal: Nationwide analysis of suspected adverse events following COVID-19 vaccination in Germany.The International journal of risk & safety in medicine2026name in abstract: Vaxzevria
PMID 42161097Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study.Vaccine2026name in title: AZD1222
PMID 42347629Critical Path to First-in-Human Batches of ChAdOx Vectors, Including for Emergency Response.Vaccines2026name in abstract: ChAdOx1 nCoV-19
PMID 42347652Longevity and Magnitude of Antibody Responses After Homologous and Heterologous COVID-19 Booster Vaccinations in Bangladesh.Vaccines2026name in abstract: ChAdOx1 nCoV-19
PMID 42382104COVID-19 Vaccine-triggered Relapsing Immune Dysregulation: An Observational Study with Four-year Follow-up.Annals of neurosciences2026name in abstract: Covishield
PMID 42383724Minor differences in the untranslated regions of measles vector additional transcription units are reflected by differential immunogenicity of encoded MERS-CoV Spike antigen.Journal of virology2026name in abstract: Vaxzevria
PMID 42403306Potential association of cluster headache with certain COVID-19 vaccines: An assessment from the pharmacovigilance databases.Headache2026name in abstract: Vaxzevria
PMID 42409113Variations in cross-neutralizing reactivity is dependent on mutations on immunogenic epitopes in the spike protein of SARS-CoV-2 variants.Indian journal of medical microbiology2026name in abstract: Covishield
PMID 42435835Comparative analysis of non-clinical and clinical safety assessment of COVID 19 vaccines.Regulatory toxicology and pharmacology : RTP2026name in abstract: Vaxzevria
PMID 42472497ChAdOx1 nCoV-19 coronavirus vaccine: Long-term safety and immunological responses.Vaccine2026name in title: ChAdOx1 nCoV-19
PMID 42500335Assessment of Neutralizing Antibodies Against COVID-19: The Impact of Vaccination in Western Rajasthan.Indian journal of clinical biochemistry : IJCB2026name in abstract: Covishield
PMID 42513402Posterior Circulation Ischemic Stroke Occurring After ChAdOx1 nCoV-19/AZD1222 Vaccination Without Evidence of Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Case Report and Focused Narrative Review.Journal of clinical medicine2026name in title: ChAdOx1 nCoV-19
PMID 42594644Implications for future pandemics from a living systematic review and critical evaluation of observational studies of the effectiveness of COVID-19 vaccination against the Omicron variant.Vaccine2026name in abstract: ChAdOx1 nCoV-19
PMID 42625910Differential functional immune recall across homologous and heterologous COVID-19 vaccination regimens.Frontiers in immunology2026name in abstract: ChAdOx1 nCoV-19
PMID 42675735Long-term adverse effects following COVID-19 vaccination: A comparative analysis of Oxford AstraZeneca, Pfizer-BioNTech, and Moderna vaccines.Medicine2026name in abstract: ChAdOx1 nCoV-19
PMID 42731688Assessment of the immune response induced by ChAdOx1 nCoV-19 Oxford-AstraZeneca, Sputnik V, and BNT162b2 Pfizer-BioNTech vaccines during the COVID-19 epidemic outbreak in the Mexican population: Gene expression of the cytokine storm.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases2026name in title: ChAdOx1 nCoV-19
PMID 42836482Immune checkpoint inhibition enhances memory T-cell responses to CEF(T), SARS-CoV-2 spike proteins and ChAdOx1 nCoV-19.Human vaccines & immunotherapeutics2026name in title: ChAdOx1 nCoV-19
PMID 42895309TMPRSS2-coagulation nexus: a novel molecular link revealed by pairwise correlation analysis following AstraZeneca (ChAdOx1 nCoV-19) vaccination in a Nigerian cohort.Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis2026name in title: ChAdOx1 nCoV-19
PMID 42901509A multi-objective sequence engineering framework for rational genetic vaccine design.Journal of the Royal Society, Interface2026name in abstract: AZD1222
PMID 43005798Long-Term Immunogenicity, Safety, and Reactogenicity of CoronaVac and Heterologous Booster Vaccines: A Two-Year Cohort Study in Brazil.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale2026name in abstract: Covishield
PMID 43020105Nasal mucosal humoral responses to SARS-CoV-2 vaccination priming schedules in the UK: a substudy of the Com-COV single-blind, randomised, non-inferiority trial.The Lancet. Microbe2026name in abstract: ChAdOx1 nCoV-19
PMID 43022362Longitudinal antibody kinetics following 2 doses of ChAdOx1 nCoV-19 (Covishield) vaccination among laboratory personnel in a COVID-19 testing laboratory in a tertiary care hospital in Kerala: a prospective study.Clinical and experimental vaccine research2026name in title: ChAdOx1 nCoV-19
PMID 43023545mRNA-based anti-COVID-19 vaccines induced higher B cells and IgG levels than whole virus-based: A pilot study on Egyptian individuals.Human antibodies2026name in abstract: ChAdOx1 nCoV-19
PMID 36592166Humoral SARS-CoV-2 immunogenicity wanes 3 months after heterologous inactivated vaccine followed by ChAdOx1 nCoV-19 in autoimmune rheumatic diseases.Asian Pacific journal of allergy and immunology2025name in title: ChAdOx1 nCoV-19
PMID 37749309A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses.Nature biomedical engineering2025name in abstract: AZD1222
PMID 38030893COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis.Annals of hematology2025name in abstract: ChAdOx1 nCoV-19
PMID 39604225Distinct Requirements for CD4+ T Cell Help for Immune Responses Induced by mRNA and Adenovirus-Vector SARS-CoV-2 Vaccines.European journal of immunology2025name in abstract: AZD1222
PMID 39786643Globally approved vaccines for COVID-19: a systematic review.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2025name in abstract: Covishield
PMID 39789037Serological insights from SARS-CoV-2 heterologous prime and boost responses in Thailand.Scientific reports2025name in abstract: ChAdOx1 nCoV-19
PMID 39793521Retraction Notice to "New relapse of multiple sclerosis and neuromyelitis optica as a potential adverse event of AstraZeneca AZD1222 vaccination for COVID-19" [Multiple Sclerosis and Related Disorders 57 (2022) 103321].Multiple sclerosis and related disorders2025name in title: AZD1222
PMID 39826861Safety and humoral immunogenicity of the ChAdOx1 nCoV-19 vaccine administered as a fourth dose booster following two doses of ChAdOx1 nCoV-19 and a third dose of BNT162b2 (COV009): A prospective cohort study.The Journal of infection2025name in title: ChAdOx1 nCoV-19
PMID 39835239Persistence of SARS-CoV-2 Antibodies for a Year Following SARS-CoV-2 Vaccinations (BBV152 and ChAdOx1 nCoV-19).Indian journal of clinical biochemistry : IJCB2025name in title: ChAdOx1 nCoV-19
PMID 39836896Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case-control study.European journal of public health2025name in title: AZD1222
PMID 39843797Empowering African Expertise: Enhancing Safety Data Integration and Signal Detection for COVID-19 Vaccines Through the African Union Smart Safety Surveillance Joint Signal Management Group.Drug safety2025name in abstract: ChAdOx1 nCoV-19
PMID 39872278Neutralizing Anti-SARS-CoV-2 Antibody Response to COVID-19 Vaccines-ChAdOx1-nCoV-19 and BBV152 Among Hemodialysis Patients.Indian journal of nephrology2025name in title: ChAdOx1 nCoV-19
PMID 39879847Safety comparison between Pfizer BNT162b2, Moderna mRNA-1273, and AstraZeneca AZD1222 in a Nationwide prospective cohort survey at the beginning of the severe acute respiratory syndrome coronavirus 2 vaccination in Japan.Vaccine2025name in title: AZD1222
PMID 39885196Identifying falsified COVID-19 vaccines by analysing vaccine vial label and excipient profiles using MALDI-ToF mass spectrometry.NPJ vaccines2025name in abstract: Covishield
PMID 39891027The COVID-19 vaccine ChAdOx1 is opsonized by anti-vector antibodies that activate complement and promote viral vector phagocytosis.Scandinavian journal of immunology2025name in abstract: ChAdOx1 nCoV-19
PMID 39911379Humoral and cellular immune durability of different COVID-19 vaccine platforms following homologous/heterologous boosters: one-year post vaccination.Frontiers in immunology2025name in abstract: ChAdOx1 nCoV-19
PMID 39931482Impact of immunosuppressive regimens on antibody response after COVID-19 vaccination among Thai kidney transplant recipients.Heliyon2025name in abstract: ChAdOx1 nCoV-19
PMID 39938313Impact in the humoral and cellular immune response to SARS-CoV-2 variants after primary vaccination with AZD1222/COVISHIELD protocol in healthy adults.Vaccine2025name in title: Covishield
PMID 39961391Immunogenicity of second booster-dose COVID-19 mRNA vaccine among older adults in Taiwan.Biomedical journal2025name in abstract: ChAdOx1 nCoV-19
PMID 39962455Monitoring and active surveillance of adverse events following the booster dose of AZD1222 vaccine in people vaccinated with Sinopharm BBIBP-CorV: a cohort study.BMC public health2025name in title: AZD1222
PMID 39989580Long-term antibody responses to COVAXIN and COVISHIELD vaccines in rheumatoid arthritis patients and healthy control population - A cross-sectional study.Journal of family medicine and primary care2025name in title: Covishield
PMID 40006648Profile of Humoral Immunity and B Cell Pool in Infection with the SARS-CoV-2 Prototype Strain and AZD1222 (ChAdOx nCoV-19) Vaccination.Vaccines2025name in title: AZD1222
PMID 40006661Comparison of Phenotypes of Headaches After COVID-19 Vaccinations Differentiated According to the Vaccine Used.Vaccines2025name in abstract: Vaxzevria
PMID 40025095Cellular immune breadth of an Omicron-specific, self-amplifying monovalent mRNA vaccine booster for COVID-19.NPJ vaccines2025name in abstract: ChAdOx1 nCoV-19
PMID 40028315Report on adverse events of COVID-19 vaccines in Iran: a comprehensive national prospective longitudinal analysis.Frontiers in immunology2025name in abstract: Vaxzevria
PMID 40034661Serious adverse events following immunization and predictors of mortality associated with COVID-19 vaccination in India: a secondary data analysis of nationwide causality assessments.Therapeutic advances in vaccines and immunotherapy2025name in abstract: Covishield
PMID 40036106Comparative efficacy of leading COVID-19 vaccines: A network meta-analysis.The Indian journal of medical research2025name in abstract: Covishield
PMID 40036131Robust public health evidence should concede multifactorial causation.Indian journal of medical ethics2025name in abstract: Covishield
PMID 40041786Self-Reported Adverse Events Following COVID-19 Vaccination Among Medical Sciences Students After a Symptomatology Training Program: A Cross-Sectional Study.Health science reports2025name in abstract: AZD1222
PMID 40060063Antibody Response to Covishield and Covaxin in Kidney Transplant Recipients.Indian journal of nephrology2025name in title: Covishield
PMID 40083966Immunogenicity and reactogenicity of fractional vs. full booster doses of COVID-19 vaccines: a non-inferiority, randomised, double-blind, phase IV clinical trial in Brazil.Lancet regional health. Americas2025name in abstract: AZD1222
PMID 40085945Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopenia.Blood advances2025name in abstract: ChAdOx1 nCoV-19
PMID 40097436Differential efficacy of first licensed western vaccines protecting without immunopathogenesis Wuhan-1-challenged hamsters from severe COVID-19.NPJ vaccines2025name in abstract: Vaxzevria
PMID 40114918Enhanced T-cell immunity and lower humoral responses following 5-dose SARS-CoV-2 vaccination in patients with inborn errors of immunity compared with healthy controls.Frontiers in immunology2025name in abstract: ChAdOx1 nCoV-19
PMID 40115569Safety, immunogenicity, and breakthrough infections during 1-year follow-up after COVISHIELD™ vaccination among healthcare workers in a teaching institute in North India: A prospective longitudinal study.Journal of family medicine and primary care2025name in title: Covishield
PMID 40124791A Cross-Sectional Study on Side Effects of "Corbevax" Covid-19 Vaccine among 12- to 14-Year Age Group in a Tertiary Care Hospital in Meerut, Uttar Pradesh.Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine2025name in abstract: Covishield
PMID 40127572A rapid human vaccine process development map outlining lessons learnt from ChAdOx1 nCoV-19 vaccine during the COVID-19 pandemic.Vaccine2025name in title: ChAdOx1 nCoV-19
PMID 40204579Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study.The Lancet. Digital health2025name in title: Vaxzevria
PMID 40214314Comparing ChAdOx1 nCoV-19 Coronavirus Vaccine (Recombinant) (Covishield) and BBV152; Bharat Biotech COVID-19 Vaccine (Covaxin) for COVID-19: Reports of Adverse Events Following Vaccination among the Indian Population.Indian journal of public health2025name in title: ChAdOx1 nCoV-19
PMID 40266230Robust COVID-19 Vaccine Responses Despite Filarial Co-Infection: Insights from a Lymphatic Filariasis Cohort in Ghana.Vaccines2025name in abstract: Vaxzevria
PMID 40269252Effect of heterologous intranasal iNCOVACC® vaccination as a booster to two-dose intramuscular Covid-19 vaccination series: a randomized phase 3 clinical trial.Communications medicine2025name in abstract: Covishield
PMID 40316343Safety and utilisation of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine: a UK post-authorisation active surveillance study.BMJ open2025name in title: ChAdOx1 nCoV-19
PMID 40340265Risk of new-onset seizures following immunization against COVID-19: a self-controlled case-series study.Epidemiology and health2025name in abstract: ChAdOx1 nCoV-19
PMID 40347503Immunological memory in infected & exposure näive individuals one year post SARS-CoV-2 vaccination.The Indian journal of medical research2025name in abstract: Covishield
PMID 40348868Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines.Communications medicine2025name in abstract: ChAdOx1 nCoV-19
PMID 40354431Ambient air pollution exposure and effects on neutralizing antibody titers following SARS-CoV-2 vaccination in adults.PLOS global public health2025name in abstract: AZD1222
PMID 40359433Shear-dependent platelet aggregation by ChAdOx1 nCoV-19 vaccine: a novel biophysical mechanism for arterial thrombosis.Blood2025name in title: ChAdOx1 nCoV-19
PMID 40381868The type of the first prime/boost vaccine against SARS-CoV-2 exerts long-term effects on the humoral immune response.Clinical immunology (Orlando, Fla.)2025name in abstract: AZD1222
PMID 40390965COVID-19 Vaccination and Infection: Effect on Maternal and Cord Blood Antibody Levels at Delivery.Journal of obstetrics and gynaecology of India2025name in abstract: Covishield

NIH grants

ProjectTitleOrganisationPIYearsLinked by
P01HL167668The Immunobiology of Vaccine-induced Immune Thrombotic ThrombocytopeniaVERSITI BLOOD HEALTH, INC.PONCZ, MORTIMER2024–2026name in project terms: AZD1222
ZIAAI001289Virus Ecology Unit - COVID-19 responseNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESMUNSTER, VINCENT2021–2025name in abstract: AZD1222
R56AI187084Enhancing HIV-1 vaccines by altering vaccine doseNORTHWESTERN UNIVERSITYPENALOZA-MACMASTER, PABLO2024–2024name in abstract: ChAdOx1 nCoV-19
UL1TR002366Frontiers Clinical and Translational Science Institute at the University of KansasUNIVERSITY OF KANSAS MEDICAL CENTERCASTRO, MARIO2022–2024name in project terms: AZD1222
UM1AI068618CoVPN 3003 A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older LC 3FRED HUTCHINSON CANCER RESEARCH CENTERMCELRATH, MARGARET JULIANA2020–2022name in title: AZD1222
UM1AI068635CoVPN 3003 - A Phase 3 Study to Assess the Efficacy and Safety of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults Aged 18 Years and Older SDMCFRED HUTCHINSON CANCER CENTERGILBERT, PETER B.2021–2022name in title: AZD1222
UM1AI148574Establishment of the New York University Vaccine and Treatment Evaluation Unit (NYU VTEU)NEW YORK UNIVERSITY SCHOOL OF MEDICINEMULLIGAN, MARK JOSEPH2020–2020name in abstract: AZD1222

Notes

AZD1222: replication-deficient chimpanzee adenovirus ChAdOx1 (derived from chimpanzee adenovirus Y25) encoding the full-length SARS-CoV-2 spike with a tPA leader. Two intramuscular doses. First authorised by the MHRA on 30 December 2020 and given conditional marketing authorisation in the EU on 29 January 2021 as Vaxzevria; licensed to the Serum Institute of India as Covishield and authorised in many other countries, which are not all listed here. AstraZeneca withdrew the EU authorisation in 2024 for commercial reasons (not verified from an agency source here). 'ChAdOx1' alone is the platform and is not listed as an alias.

How to cite

ChAdOx1 nCoV-19 (AXP000167.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000167.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.